757:(ABI). The ABI is a simple, non-invasive test that measures the ratio of systolic blood pressure in the ankle to the systolic blood pressure in the upper arm. This is based on the idea that if blood pressure readings in the ankle are lower than those in the arm, a blockage in the arteries that provide blood from the heart to the ankle is suspected. An ABI range of 0.90 to 1.40 is considered normal. A person is considered to have PAD when the ABI is ≤ 0.90. However, PAD can be further graded as mild to moderate if the ABI is between 0.41 and 0.90, and severe if the ABI is less than 0.40. These categories can provide insight into the disease course. Furthermore, ABI values of 0.91 to 0.99 are considered borderline, and values >1.40 indicate
680:) to the lower limbs can be classified as either functional or critical. Functional ischemia occurs when the blood flow is normal at rest but insufficient during exercise, presenting clinically as intermittent claudication. Critical ischemia is produced when the reduction in blood flow results in a perfusion deficit at rest and is defined by the presence of pain at rest or trophic lesions in the legs. In this situation, precise diagnosis is fundamental, as there is a clear risk of loss of the limb if adequate blood flow is not re-established, either by surgery or by endovascular therapy. Differentiating between the two concepts is important in order to establish the therapeutic indication and the prognosis in patients with PAD.
1125:
53:
520:
1318:, but the trial has been criticized as being underpowered, limiting endovascular options, and comparing inappropriate endpoints. As of 2017, two randomized clinical trials are being conducted to better understand the optimal revascularization technique for severe PAD and critical limb ischemia (CLI), the BEST-CLI (Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia) Trial and the BASIL-2 (Bypass Versus Angioplasty in Severe Ischaemia of the Leg – 2 )Trial.
445:(IC), which typically refers to lower extremity skeletal muscle pain that occurs during exercise. IC presents when there is insufficient oxygen delivery to meet the metabolic requirements of the skeletal muscles. IC is a common manifestation of peripheral arterial disease (PAD). The pain is usually located in the calf muscles of the affected leg and is relieved by rest. This occurs because during exercise, the muscles require more
804:(CT) scanners provide direct imaging of the arterial system. Studies have shown the sensitivity and specificity of CT in identifying lesions with >50% stenosis to be 95% and 96%, respectively. As such, CT may be considered as an alternative to invasive angiography. An important distinction between the two is that, unlike invasive angiography, assessment of the arterial system with CT does not allow for vascular intervention.
651:
701:
819:
433:
449:. Normally, the arteries would be able to increase the amount of blood flow and therefore increase the amount of oxygen going to the exercised muscle. However, in PAD, the artery is unable to respond appropriately to the increased demand for oxygen from the muscles, and as a result, the muscles are deprived of oxygen, leading to muscle pain that subsides with rest.
810:(MRA) is a noninvasive diagnostic procedure that uses a combination of a large magnet, radio frequencies, and a computer to produce detailed images of blood vessels inside the body. The advantages of MRA include its safety and ability to provide high-resolution, three-dimensional imaging of the entire abdomen, pelvis, and lower extremities in one sitting.
541:), which can lead to atherosclerosis. Smokers are 2-3 times more likely to have lower extremity PAD than coronary artery disease. Greater than 80%–90% of patients with lower extremity peripheral arterial disease are current or former smokers. The risk of PAD increases with the number of cigarettes smoked per day and the number of years smoked.
909:. This system was created on the basis that ischemia and angiographic disease patterns are not the sole determinants of amputation risk. The WIfI classification system is broken up into two parts: wounds and ischemia. Wounds are graded 0 through 3 based on the presence of ulceration, gangrene, and ischemia.
1278:
The incidence of symptomatic PAD increases with age, from about 0.3% per year for men aged 40–55 years to about 1% per year for men aged over 75 years. The prevalence of PAD varies considerably depending on how PAD is defined and the age of the population being studied. People diagnosed with PAD have
768:
Individuals with suspected PAD with normal ABIs can undergo exercise testing for ABI. A baseline ABI is obtained prior to exercise. The patient is then asked to exercise (usually patients are made to walk on a treadmill at a constant speed) until claudication pain occurs (for a maximum of 5 minutes),
1232:
for the diagnosis and treatment of lower extremity, renal, mesenteric, and abdominal aortic PAD was compiled in 2013, combining the 2005 and 2011 guidelines. For chronic limb-threatening ischemia, the ACCF/AHA guidelines recommend balloon angioplasty only for people with a life expectancy of 2 years
1080:
therapy). The recommended daily dosage of aspirin for treating PAD is between 75 and 325 mg, while the recommended daily dosage for clopidogrel is 75 mg. The effectiveness of both aspirin and clopidogrel to reduce the risk of cardiovascular ischemic events in people with symptomatic PAD is
1024:
often improves. Treadmill exercise (35 to 50 minutes, three or four times per week) has been reviewed as another treatment with a number of positive outcomes, including a reduction in cardiovascular events and improved quality of life. Supervised exercise programs increase pain-free walking time and
587:
Other risk factors that are being studied include levels of various inflammatory mediators such as C-reactive protein, fibrinogen, homocysteine, and lipoprotein A. Individuals with increased levels of homocysteine in their blood have a 2-fold risk of developing peripheral artery disease. While there
523:
The illustration shows how PAD can affect arteries in the legs. Figure A shows a normal artery with normal blood flow. The inset image shows a cross-section of the normal artery. Figure B shows an artery with plaque buildup that is partially blocking blood flow. The inset image shows a cross-section
2097:
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. (March 2017). "2016 AHA/ACC Guideline on the
Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association
1290:
diabetes, respectively, demonstrated that glycemic control is more strongly associated with microvascular disease than macrovascular disease. Pathologic changes occurring in small vessels may be more sensitive to chronically elevated glucose levels than atherosclerosis occurring in larger arteries.
981:
Some studies propose the development of devices measuring oxygen continuously during exercise. This is because resting perfusion and metabolic activity are extremely low and differences between non-patients and PAD patients are barely measurable. As such, testing of vascular function and energetics
745:
when the affected limb is in an elevated position. The limb is then moved from an elevated to a sitting position and checked for redness, which is called reactive hyperemia. Buerger's test is an assessment of arterial sufficiency, which is the ability of the artery to supply oxygenated blood to the
687:
thrombosis related to hypercoagulable states. Additional mechanisms of peripheral artery disease include arterial spasm and fibromuscular dysplasia. The cause and pathophysiology of arterial spasm are not fully understood, but it is hypothesised that they can occur secondary to trauma. The symptoms
528:
Factors contributing to an increased risk of PAD are the same as those for atherosclerosis. These include age, sex, and ethnicity. PAD is twice as common in males as in females. In terms of ethnicity, PAD is more common in people of color compared to the white population in a 2:1 ratio. The factors
423:
In 2015, about 155 million people had PAD worldwide. It becomes more common with age. In the developed world, it affects about 5.3% of 45- to 50-year-olds and 18.6% of 85- to 90-year-olds. In the developing world, it affects 4.6% of people between the ages of 45 and 50 and 15% of people between the
1142:
and decrease with arteries towards the toes. Other criteria that affect the outcome following revascularization are the length of the lesion and the number of lesions. There do not appear to be any long-term advantages or sustained benefits to placing a stent following angioplasty in order to hold
986:
can be inconvenient to wear during exercise and only give oxygen values at discrete time points, nor is there sufficient evidence to support any use in identifying PAD. Some publications and studies therefore discuss the use of wearable sensors measuring oxygen levels continuously in PAD patients,
708:
Diagnosing or identifying peripheral artery disease requires a history of symptoms and a physical exam, followed by confirmatory testing. These tests could include CT scans (Computed
Tomographic Angiography), MRA scans (Magnetic Resonance Angiography), or ultrasounds for imaging. In the setting of
1263:
affects 12–20 percent of
Americans age 65 and older. Around 10 million Americans have PAD. Despite its prevalence and implications for cardiovascular risk, there are still low levels of awareness of risk factors and symptoms, with 26% of the population in the US reported to have knowledge of PAD.
1262:
The prevalence of PAD in the general population is 3–7%, affecting up to 20% of those over 70; 70%–80% of affected individuals are asymptomatic; only a minority ever require revascularization or amputation. Peripheral artery disease affects one in three diabetics over the age of 50. In the US, it
709:
symptoms consistent with peripheral artery disease, a physician will then examine an individual for specific exam findings. Abnormal physical exam findings can lead a health care provider to consider a specific diagnosis. However, in order to confirm a diagnosis, confirmatory testing is required.
1249:
Individuals with PAD have an "exceptionally elevated risk for cardiovascular events and the majority will eventually die of a cardiac or cerebrovascular etiology". Prognosis is correlated with the severity of the PAD as measured by an ABI. Large-vessel PAD increases mortality from cardiovascular
3643:– describes ABI procedure, interpretation of results, and notes the somewhat arbitrary selection of "ABI of 0.8 has become the accepted endpoint for high-compression therapy, the trigger for referral for a vascular surgical opinion and the defining upper marker for an ulcer of mixed aetiology.
904:
came out with a classification system based on "wound, ischemia and foot infection" (WIfI). This classification system, published in 2013, was created to account for the demographic changes that have occurred over the past forty years, including the increased incidence of high blood sugar and
669:
The pathophysiology of atherosclerosis involves complex interactions between cholesterol and vascular cells. In the early stages of PAD, the arteries compensate for the plaque buildup by dilating to preserve flow through the vessel. Eventually, the artery cannot dilate any further, and the
1253:
The risk is low that an individual with claudication will develop severe ischemia and require amputation, but the risk of death from coronary events is three to four times higher than matched controls without claudication. Of patients with intermittent claudication, only "7% will undergo
1095:
is of unclear benefit. Cilostazol may improve walking distance for people who experience claudication due to peripheral artery disease, but no strong evidence suggests that it improves the quality of life, decreases mortality, or decreases the risk of cardiovascular events.
2266:
Lin JS, Olson CM, Johnson ES, Whitlock EP (September 2013). "The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive
Services Task Force".
548:
is shown to increase the risk of PAD by 2-4 fold. It does this by causing endothelial and smooth-muscle cell dysfunction in peripheral arteries. The risk of developing lower extremity peripheral arterial disease is proportional to the severity and duration of
4818:"2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines"
3268:
Ridker PM, Stampfer MJ, Rifai N (May 2001). "Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease".
424:
ages of 85 and 90. PAD in the developed world is equally common among men and women, though in the developing world, women are more commonly affected. In 2015, PAD resulted in about 52,500 deaths, which is an increase from the 16,000 deaths in 1990.
1279:
a greater risk of a MACE (Major
Adverse Cardiac Event) and stroke. Their risk of developing a reinfarction, stroke, or transient ischemic attack within one year following a heart attack increases to 22.9%, compared to 11.4% for those without PAD.
572:
levels. This abnormality in blood cholesterol levels has been correlated with accelerated peripheral artery disease. Management of dyslipidemia by diet, exercise, and/or medication is associated with a major reduction in rates of heart attack and
3181:
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. (October 2005). "Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins".
1577:
Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. (October 2013). "Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis".
2974:"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines"
588:
are genetic factors leading to risk factors for peripheral artery disease, including diabetes and high blood pressure, there have been no specific genes or gene mutations directly associated with the development of peripheral artery disease.
995:
as opposed to transcutaneously may most effectively help monitor a PAD patient’s progress and direct therapy decisions. To date, one oxygen sensing system has been approved for use in Europe to measure tissue perfusion in all PAD patients.
486:. Critical limb ischemia occurs when the obstruction of blood flow in the artery is compromised to the point where the blood is unable to maintain oxygenation of the tissue at rest. This can lead to pain at rest, a feeling of coldness, or
5530:"2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines"
440:
The signs and symptoms of peripheral artery disease are based on the part of the body that is affected. About 66% of patients affected by PAD either do not have symptoms or have atypical symptoms. The most common presenting symptom is
5468:
Deev RV, Bozo IY, Mzhavanadze ND, Voronov DA, Gavrilenko AV, Chervyakov YV, et al. (September 2015). "pCMV-vegf165 Intramuscular Gene
Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia".
826:
The two most commonly used methods to classify peripheral artery disease are the
Fontaine and Rutherford systems of classification. The Fontaine stages were introduced by René Fontaine in 1954 to define the severity of chronic limb
665:
of peripheral artery disease, especially in patients over 40 years old, is atherosclerosis. Atherosclerosis is a narrowing of the arteries caused by lipid or fat buildup and calcium deposition in the wall of the affected arteries.
400:, which helps with thinning the blood and thus improving blood flow, does not appear to help those with mild disease but is usually recommended for those with more significant disease due to the increased risk of heart attacks.
3731:
Shwaiki O, Rashwan B, Fink MA, Kirksey L, Gadani S, Karuppasamy K, et al. (October 2021). "Lower extremity CT angiography in peripheral arterial disease: from the established approach to evolving technical developments".
1266:
In 2000, among people aged 40 years and older in the United States, rates of PAD were 4.3%. Rates were 14.5% for people aged 70 years or over. Within age groups, rates were generally higher for women than men. Non-Hispanic
4352:
1254:
lower-extremity bypass surgery, 4% major amputations, and 16% worsening claudication", but stroke and heart attack events are elevated, and the "5-year mortality rate is estimated to be 30% (versus 10% in controls)".
506:. People with diabetes are affected by gangrene of the feet at a rate that is 30 times higher than the unaffected population. Many of these severe complications, such as those leading to amputation, are irreversible.
529:
with the greatest risk associations are hyperlipidemia, hypertension, diabetes mellitus, chronic kidney disease, and smoking. Presenting three of these factors or more increases the risk of developing PAD tenfold.
1076:, and other causes of vascular death in people with symptomatic peripheral artery disease. It is recommended that aspirin and clopidogrel be taken alone and not in conjunction with one another (i.e., not as dual
761:. If an ABI >1.40 is calculated, this could indicate vessel wall stiffness caused by calcification, which can occur in people with uncontrolled diabetes. Abnormally high ABIs (>1.40) are usually considered
5603:
5588:
3775:
Leiner T, Kessels AG, Nelemans PJ, Vasbinder GB, de Haan MW, Kitslaar PE, et al. (May 2005). "Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis".
688:
of claudication ensue when the artery spasms, or clamps down on itself, creating an obstruction. Similar to atherosclerosis, this leads to decreased blood flow to the tissue downstream of the obstruction.
5257:
Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. (December 2005). "Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial".
1880:"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015"
658:
Peripheral arterial disease is considered to be a set of chronic or acute syndromes, generally derived from the presence of occlusive arterial disease, which causes inadequate blood flow to the limbs.
3688:
Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ (January 2009). "Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis".
3146:
Beks PJ, Mackaay AJ, de
Neeling JN, de Vries H, Bouter LM, Heine RJ (January 1995). "Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study".
765:, and thus, such results merit further investigation and higher-level studies. Individuals with noncompressible arteries have an increased risk of cardiovascular mortality within a two-year period.
4798:
1828:"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015"
2406:"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013"
966:(AAA), there is no data on screening individuals with asymptomatic PAD for abdominal aortic aneurysms. For people with symptomatic PAD, screening by ultrasound for AAA is not unreasonable.
380:
for peripheral artery disease in people without symptoms is useful, as it has not been properly studied. For those with intermittent claudication from PAD, stopping smoking and supervised
1064:
reduce clot formation and cholesterol levels, respectively, and can help with disease progression and address the other cardiovascular risks that the affected person is likely to have.
533:
Smoking – Tobacco use in any form is the single greatest risk factor for peripheral artery disease internationally. Smokers have up to a 10-fold increase in the risk of PAD in a
580:
or elevated blood pressure can increase a person's risk of developing PAD. Similarly to PAD, there is a known association between high blood pressure and heart attacks, strokes, and
1927:
4113:"Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement"
1507:
5165:
Suzuki J, Shimamura M, Suda H, Wakayama K, Kumagai H, Ikeda Y, et al. (April 2016). "Current therapies and investigational drugs for peripheral arterial disease".
283:
disease. PAD means the arteries are narrowed or blocked—the vessels that carry oxygen-rich blood as it moves away from the heart to other parts of the body. Peripheral
758:
6480:
1211:, a minimally-invasive method which uses ultrasound waves to break up plaque within the artery without need for penetration. The method was first approved by the US
991:
means. However, because transcutaneous measurements are affected by movement (such as during exercise) and body temperature, use of oxygen sensors that are inserted
2856:"Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study"
5030:"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000"
863:
and the
International Society of Cardiovascular Surgery, introduced in 1986 and revised in 1997 (and known as the Rutherford classification after the lead author,
4072:"The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)"
4028:"The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)"
1344:"Creating the Ideal Microcosm for Rapid Incorporation of Bioengineered Alternative Tissues Using An Advanced Hydrogel Impregnated Gauze Dressing: A Case Series"
1115:
After a trial of the best medical treatment outlined above, if symptoms persist, patients may be referred to a vascular or endovascular surgeon. The benefit of
3638:
893:
Moderate to severe PAD, classified by
Fontaine's stages III to IV or Rutherford's categories 4 to 5, presents a limb threat (risk of limb loss) in the form of
1299:
Research is being done on therapies to prevent the progression of PAD. In those who have developed critically poor blood flow to the legs, the benefit of
1826:
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016).
3390:, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Rutherford RB (June 2007). "Inter-society consensus for the management of peripheral arterial disease".
584:. High blood pressure increases the risk of intermittent claudication, the most common symptom of PAD, by 2.5- to 4-fold in men and women, respectively.
955:
It is not clear if screening for disease in the general population is useful, as it has not been extensively studied. This includes screening with the
5303:"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia"
3653:
Amini A, Gordon I, Wilson S, Williams RA (October 2013). "Noncompressible arteries correlate with increased cardiovascular mortality at 2 years".
2187:"Peripheral artery disease screening and cardiovascular disease risk assessment with the ankle-brachial index in adults: recommendation statement"
974:
A 2022 review found that a variety of wearable medical devices measuring different parameters (such as body temperature) were being combined with
1119:
is thought to correspond to the severity of ischemia and the presence of other risk factors for limb loss, such as wound and infection severity.
1707:
1628:
2936:
Cole CW, Hill GB, Farzad E, Bouchard A, Moher D, Rody K, Shea B (October 1993). "Cigarette smoking and peripheral arterial occlusive disease".
2602:
1546:
1428:
5446:
4564:
5706:
2310:
Poredos P, Jezovnik MK (March 2013). "Is aspirin still the drug of choice for management of patients with peripheral arterial disease?".
17:
673:
When there is an imbalance between the needs of the peripheral tissues and the blood supply, we are faced with a situation of ischemia.
373:
may also be used. Angiography is more accurate and allows for treatment at the same time; however, it is associated with greater risks.
6279:
4353:"Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen"
1469:
5344:"Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial"
2676:
1099:
Treatment with other drugs or vitamins is unsupported by clinical evidence, "but trials evaluating the effect of folate and vitamin B
5151:
4799:"Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter – P200039"
556:, which is an abnormally high level of cholesterol or fat in the blood. Dyslipidemia is caused by a high level of a protein called
4648:
Emmerich J (December 2005). "Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy".
5393:"Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial"
959:(ABI), although a systematic review of the literature did not support the use of routine ABI screening in asymptomatic patients.
4432:
Hussain MA, Wheatcroft M, Nault P, Lindsay TF, Bhatt DL, Anand SS, Verma S, Al-Omran M (2019). "COMPASS for Vascular Surgeons".
3225:
Kannel WB, McGee DL (January 1985). "Update on some epidemiologic features of intermittent claudication: the Framingham Study".
1496:
3021:
Kannel WB, McGee DL (1979). "Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study".
4524:
Fowkes FG, Gillespie IN (2000). Fowkes G (ed.). "Angioplasty (versus non surgical management) for intermittent claudication".
6051:
4318:
4195:"Smart Wearable Systems for the Remote Monitoring of Selected Vascular Disorders of the Lower Extremity: A Systematic Review"
1393:
933:
Grade 1: arterial brachial index 0.6 to 0.79, ankle systolic pressure 70 to 100 mm Hg, toe pressure 40 to 59 mm Hg
6056:
654:
Illustration of how the buildup of lipids cause a blockage of blood flow to the portion of the artery below the narrowing.
773:
614:
Age less than 50 years, with diabetes and one other atherosclerosis risk factor (smoking, dyslipidemia, hypertension, or
3582:"Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association"
2198:
1960:
6485:
2455:"Education in wound care: Curricula for doctors and nurses, and experiences from the German wound healing society ICW"
3564:
2578:
2381:
2062:
988:
3630:
1734:"Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication"
1153:, in which the plaque is scraped off the inside of the vessel wall (albeit with no better results than angioplasty).
962:
Testing for coronary artery disease or carotid artery disease is of unclear benefit. While PAD is a risk factor for
792:
is taken. Any blood flow-limiting blockage found in the X-ray can be identified and treated by procedures including
6206:
5823:
5210:"Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia"
1314:. The trial found no difference in amputation-free survival between vascular bypass and angioplasty at the planned
5838:
5699:
1139:
6157:
1225:
1045:
807:
287:
disease, on the other hand, refers to problems with veins—the vessels that bring the blood back to the heart.
5969:
754:
358:
302:, cold skin, or abnormal nail and hair growth in the affected leg. Complications may include an infection or
2695:"Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men"
1943:
Disorders of arteries that supply the brain with blood are considered separately as cerebrovascular disease.
943:
The TASC (and TASC II) classification suggests PAD treatment is based on the severity of disease seen on an
46:
Peripheral vascular disease (PVD), peripheral artery occlusive disease, peripheral obliterative arteriopathy
6274:
6194:
5899:
1212:
901:
886:
Grade III, Category 5: minor tissue loss; ischemic ulceration not exceeding ulcer of the digits of the foot
860:
769:
after which the ankle pressure is again measured. A decrease in ABI of 15%–20% would be diagnostic of PAD.
495:
295:
94:
61:
1134:(or percutaneous transluminal angioplasty) can be done on solitary lesions in large arteries, such as the
6289:
6284:
6011:
6001:
5528:
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. (March 2017).
1307:
1282:
The Diabetes Control and Complications Trial and the UK Prospective Diabetes Study trials in people with
1788:
Hankey GJ, Norman PE, Eikelboom JW (February 2006). "Medical treatment of peripheral arterial disease".
408:
show no definitive scientific evidence of benefit in PAD. Surgical procedures used to treat PAD include
6390:
6041:
6016:
5833:
5762:
5692:
1229:
1040:
537:. Exposure to second-hand smoke has also been shown to promote changes in the lining of blood vessels (
534:
6415:
6358:
6006:
5959:
5809:
4599:
Johnston KW, Rae M, Hogg-Johnston SA, Colapinto RF, Walker PM, Baird RJ, et al. (October 1987).
3107:"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II"
1699:
1624:
1523:
Peripheral artery disease (PAD) is the narrowing of the arteries to the legs, stomach, arms and head.
1069:
975:
963:
611:
All people between 50 and 69 who have a cardiovascular risk factor (particularly diabetes or smoking)
581:
442:
291:
90:
3066:"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I"
1991:
Shantulli S (2018). "Update on peripheral arterial disease: Epidemiology and evidence-based facts".
1376:
Violi F, Basili S, Berger JS, Hiatt WR (2012). "Antiplatelet Therapy in Peripheral Artery Disease".
936:
Grade 2: ABI 0.4–0.59, ankle systolic pressure 50 to 70 mm Hg, toe pressure 30 to 39 mm Hg
776:
to look at the site of obstruction and extent of atherosclerosis. Other imaging can be performed by
6400:
6213:
6167:
6162:
5986:
5964:
5618:
1287:
1283:
1004:
Depending on the severity of the disease, these steps can be taken, according to these guidelines:
565:
74:
5122:"HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study"
1538:
6455:
6437:
5919:
5914:
5878:
5848:
5515:
4070:
Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G (January 2014).
4026:
Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G (January 2014).
1420:
801:
601:
All people who have leg symptoms with exertion (suggestive of claudication) or ischemic rest pain
557:
362:
350:
311:
261:
257:
106:
5208:
Moazzami B, Mohammadpour Z, Zabala ZE, Farokhi E, Roohi A, Dolmatova E, Moazzami K (July 2022).
4154:"A systematic review for the screening for peripheral arterial disease in asymptomatic patients"
2693:
Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ (October 2012).
1124:
6427:
6410:
6405:
6395:
6236:
6172:
5814:
5715:
5442:
4816:
Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. (November 2011).
4301:
Nichols S (2019). "Long-Term in Vivo Oxygen Sensors for Peripheral Artery Disease Monitoring".
3580:
Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. (December 2012).
2775:
1311:
1215:
in February 2021, and has been used as a complement to more widely-used methods of atherectomy.
1035:
894:
800:. Contrast angiography is the most readily available and widely used imaging technique. Modern
479:
366:
167:
5658:
4923:
Chan KA, Junia A (March 2020). "Lower extremity peripheral artery disease: a basic approach".
1250:
disease significantly. PAD carries a greater than "20% risk of a coronary event in 10 years".
6432:
6177:
6036:
6028:
5996:
5883:
5342:
Menard MT, Farber A, Assmann SF, Choudhry NK, Conte MS, Creager MA, et al. (July 2016).
939:
Grade 3: ABI ≤0.39, ankle systolic pressure <50 mm Hg, toe pressure <30 mm Hg
867:). This classification system consists of four grades and seven categories (categories 0–6):
635:
52:
4254:"Oxygenation and flow in the limbs: Novel methods to characterize peripheral artery disease"
3931:
Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN (September 1997).
2280:
6346:
6341:
6145:
5937:
4979:
2972:
Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss L, et al. (April 2013).
2897:"Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study"
1461:
1160:
1138:, but may not have sustained benefits. Patency rates following angioplasty are highest for
1104:
956:
864:
615:
499:
377:
334:
163:
150:
5391:
Popplewell MA, Davies H, Jarrett H, Bate G, Grant M, Patel S, et al. (January 2016).
4874:"Epidemiology, classification, and modifiable risk factors of peripheral arterial disease"
4111:
Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. (July 2018).
3933:"Recommended standards for reports dealing with lower extremity ischemia: revised version"
1013:
Stopping smoking (cigarettes promote PAD and are a risk factor for cardiovascular disease)
519:
337:. PAD is primarily caused by the buildup of fatty plaque in the arteries, which is called
8:
6422:
6189:
5607:
5121:
4152:
Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, et al. (March 2015).
1300:
1197:
1159:
grafting can be performed to circumvent a diseased area of the arterial vasculature. The
1144:
848:
5069:
Bauersachs R, Zeymer U, Brière JB, Marre C, Bowrin K, Huelsebeck M (November 26, 2019).
4983:
3503:"A review of the pathophysiology and potential biomarkers for peripheral artery disease"
2162:
2137:
930:
Grade 0: ABI ≥0.80, ankle systolic pressure ≥100 mm Hg, toe pressure ≥60 mm Hg
926:
Ischemia is graded 0 through 3 based on ABI, ankle systolic pressure, and toe pressure.
268:, but other arteries may also be involved, such as those of the arms, neck, or kidneys.
6336:
6246:
5828:
5554:
5529:
5521:
5494:
5419:
5392:
5368:
5343:
5283:
5234:
5209:
5190:
5138:
5097:
5070:
5046:
5029:
5002:
4967:
4948:
4900:
4873:
4842:
4817:
4779:
4766:
4741:
4717:
4692:
4673:
4625:
4600:
4581:
4573:
4501:
4476:
4457:
4409:
4384:
4329:
4278:
4253:
4229:
4194:
3998:
3973:
3863:
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. (2007).
3842:
3829:
3812:
3757:
3713:
3611:
3529:
3502:
3445:
3316:
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. (2007).
3250:
3238:
3207:
3123:
3106:
3082:
3065:
3046:
2998:
2973:
2836:
2719:
2694:
2644:
2617:
2596:
2481:
2454:
2430:
2405:
2292:
2243:
2218:
1904:
1879:
1852:
1827:
1758:
1733:
1603:
1325:
drug for the treatment of PAD, including the advanced stage of critical limb ischemia.
1021:
922:
Grade 3: extensive, full-thickness ulcer; gangrene extending to the forefoot or midfoot
723:
290:
The classic symptom is leg pain when walking, which resolves with rest and is known as
272:
253:. PAD can happen in any blood vessel, but it is more common in the legs than the arms.
85:
5612:
5271:
5071:"Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review"
3949:
3932:
3195:
2421:
1895:
1843:
1591:
6127:
6076:
5976:
5629:
5559:
5486:
5424:
5373:
5324:
5275:
5239:
5182:
5143:
5102:
5051:
5007:
4952:
4940:
4905:
4847:
4783:
4771:
4722:
4665:
4630:
4616:
4556:
4537:
4506:
4449:
4414:
4334:
4314:
4283:
4234:
4216:
4175:
4134:
4093:
4049:
4003:
3954:
3913:
3886:
3865:"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)"
3834:
3793:
3761:
3749:
3705:
3670:
3603:
3560:
3534:
3477:
3437:
3399:
3374:
3353:"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)"
3339:
3318:"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)"
3286:
3242:
3199:
3163:
3128:
3087:
3038:
3003:
2945:
2918:
2877:
2840:
2828:
2724:
2649:
2584:
2574:
2516:
2486:
2435:
2387:
2377:
2354:
2345:
Hauk L (May 2012). "ACCF/AHA update peripheral artery disease management guideline".
2327:
2284:
2248:
2167:
2115:
2058:
2015:
1909:
1857:
1805:
1763:
1678:
1595:
1399:
1389:
1315:
1272:
1171:) material is often used for long grafts when adequate venous conduit is unavailable.
1116:
1049:
1017:
906:
841:
Stage IIb: intermittent claudication after walking a distance of less than 200 meters
838:
Stage IIa: intermittent claudication after walking a distance of more than 200 meters
738:
622:
545:
326:
322:
238:
181:
158:
142:
138:
69:
5498:
5287:
4677:
4461:
3717:
3615:
3449:
3254:
3211:
3050:
2671:
2217:
Brown T, Forster RB, Cleanthis M, Mikhailidis DP, Stansby G, Stewart M (June 2021).
1607:
490:
in the affected foot and toes. Other complications of severe PAD include lower limb
6132:
5781:
5684:
5549:
5541:
5478:
5414:
5404:
5363:
5355:
5314:
5267:
5229:
5225:
5221:
5194:
5174:
5133:
5092:
5082:
5041:
4997:
4987:
4932:
4895:
4885:
4837:
4829:
4761:
4757:
4753:
4712:
4708:
4704:
4657:
4620:
4612:
4552:
4548:
4529:
4496:
4492:
4488:
4441:
4404:
4396:
4324:
4306:
4273:
4265:
4224:
4206:
4165:
4124:
4083:
4039:
3993:
3985:
3944:
3876:
3846:
3824:
3785:
3741:
3697:
3662:
3593:
3524:
3514:
3429:
3387:
3364:
3329:
3278:
3234:
3191:
3155:
3118:
3077:
3030:
2993:
2985:
2908:
2867:
2818:
2714:
2706:
2639:
2629:
2476:
2466:
2425:
2417:
2319:
2296:
2276:
2238:
2234:
2230:
2157:
2153:
2149:
2107:
1899:
1891:
1847:
1839:
1797:
1753:
1749:
1745:
1668:
1587:
1381:
1351:
1271:
had a rate of 7.9% compared to 4.4% in Non-Hispanic whites and 3.0% (1.4%–4.6%) in
381:
279:
refers to both the arteries and veins within the body. PAD differs from peripheral
185:
78:
5669:
3351:
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (January 2007).
1732:
Hageman D, Fokkenrood HJ, Gommans LN, van den Houten MM, Teijink JA (April 2018).
6324:
6319:
6231:
5954:
5909:
5789:
5623:
5545:
4445:
4310:
3631:"Doppler assessment and ABPI: Interpretation in the management of leg ulceration"
3598:
3581:
1385:
1310:
has been conducted comparing vascular bypass to angioplasty for the treatment of
1238:
1234:
1156:
889:
Grade IV, Category 6: major tissue loss; severe ischemic ulcers or frank gangrene
762:
409:
338:
122:
5672:
4601:"5-year results of a prospective study of percutaneous transluminal angioplasty"
2823:
2806:
2323:
1356:
1343:
1237:
available. For those with a life expectancy greater than 2 years or who have an
1068:
According to guidelines, taking aspirin or clopidogrel is recommended to reduce
729:
Decreased temperature (coolness) in the affected limb when compared to the other
6373:
6223:
6086:
6046:
5981:
5942:
5853:
5634:
4833:
4693:"Angioplasty versus bare metal stenting for superficial femoral artery lesions"
3881:
3864:
3745:
3666:
3469:
3334:
3317:
2989:
2508:
2111:
2007:
1135:
1092:
992:
983:
781:
389:
202:
5597:
5409:
5319:
5302:
4890:
4533:
4269:
4170:
4153:
4088:
4071:
4044:
4027:
3789:
3369:
3352:
2588:
2471:
27:
Abnormal narrowing of arteries other than those that supply the heart or brain
6474:
6241:
5904:
5482:
4661:
4400:
4220:
3813:"Magnetic resonance angiography of abdominal and lower extremity vasculature"
3282:
2913:
2896:
2634:
2391:
2186:
1673:
1656:
401:
6068:
5359:
4936:
4211:
3989:
3034:
2710:
1928:"Overview of Peripheral Arterial Disease – Heart and Blood Vessel Disorders"
692:, or the formation of a blood clot, usually occurs due to stasis or trauma.
6382:
6294:
6109:
5799:
5742:
5563:
5490:
5428:
5377:
5328:
5279:
5243:
5186:
5147:
5106:
5087:
5055:
5011:
4944:
4909:
4851:
4775:
4740:
Wardle BG, Ambler GK, Radwan RW, Hinchliffe RJ, Twine CP (September 2020).
4726:
4669:
4560:
4541:
4510:
4453:
4418:
4338:
4287:
4238:
4179:
4138:
4129:
4112:
4097:
4053:
4007:
3917:
3890:
3838:
3797:
3753:
3709:
3701:
3674:
3607:
3538:
3481:
3441:
3403:
3378:
3343:
3290:
3203:
3132:
3091:
3007:
2881:
2872:
2855:
2832:
2728:
2653:
2544:
2520:
2490:
2439:
2358:
2331:
2288:
2252:
2171:
2119:
2019:
1913:
1861:
1809:
1801:
1767:
1682:
1599:
1403:
1322:
1193:
1189:
1077:
785:
628:
577:
569:
553:
342:
330:
276:
146:
126:
4634:
4570:. If this is an intentional citation to a retracted paper, please replace
3958:
3519:
3246:
3167:
3159:
2949:
2922:
1380:. Handbook of Experimental Pharmacology. Vol. 210. pp. 547–563.
6447:
5843:
5653:
4992:
3042:
2854:
Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG (March 1999).
1208:
1150:
1131:
1082:
1057:
919:
Grade 2: deep ulcer with exposed tendon or bone, gangrene limited to toes
793:
605:
561:
538:
491:
417:
413:
370:
171:
133:
5178:
5120:
Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR (April 2006).
676:
From the pathophysiologic point of view, a restriction of blood supply (
341:, especially in individuals over 40 years old. Other mechanisms include
6363:
6353:
6314:
6258:
6251:
6081:
4193:
Souza J, Escadas S, Baxevani I, Rodrigues D, Freitas A (January 2022).
1179:
1088:
689:
393:
354:
346:
307:
206:
193:
112:
5580:
4966:
Horváth L, Németh N, Fehér G, Kívés Z, Endrei D, Boncz I (July 2022).
1731:
1128:
3D Medical Animation still shot depicting the Vascular Bypass Grafting
6117:
5858:
5794:
5750:
5733:
5728:
5664:
3433:
2618:"Psychological effects of amputation: A review of studies from India"
1321:
In 2011, pCMV-vegf165 was registered in Russia as the first-in-class
944:
777:
465:
Skin that is smooth, shiny, or cool to the touch in the affected area
265:
1085:
plus aspirin is effective as a new anti-thrombotic regimen for PAD.
784:
and selectively guided to the artery in question. While injecting a
753:
If peripheral artery disease is suspected, the initial study is the
6331:
5933:
5870:
5804:
5755:
4474:
2184:
1201:
1175:
1164:
852:
828:
677:
662:
503:
487:
483:
478:
In individuals with severe PAD, complications may arise, including
432:
405:
303:
299:
98:
5527:
4475:
Broderick C, Forster R, Abdel-Hadi M, Salhiyyah K (October 2020).
3105:
Lüscher TF, Creager MA, Beckman JA, Cosentino F (September 2003).
3064:
Creager MA, Lüscher TF, Cosentino F, Beckman JA (September 2003).
2750:
2096:
1657:"Lifestyle and dietary risk factors for peripheral artery disease"
650:
436:
Peripheral arterial disease resulting in necrosis of multiple toes
5207:
4598:
4199:
International Journal of Environmental Research and Public Health
3559:(9th ed.). Elsevier, Inc. pp. Chapter 41, pgs 435–444.
2374:
Vascular medicine : a companion to Braunwald's heart disease
1421:"What Are the Signs and Symptoms of Peripheral Arterial Disease?"
1061:
1053:
969:
670:
atherosclerotic plaque starts to narrow the arterial flow lumen.
597:
Peripheral arterial disease is more common in these populations:
397:
385:
198:
2216:
365:
at the ankle divided by the systolic blood pressure of the arm.
5724:
5592:
3419:
1268:
1183:
1073:
822:
Gangrene of three toes resulting from peripheral artery disease
818:
742:
568:(HDL cholesterol), elevation of total cholesterol, and/or high
446:
315:
242:
3974:"Critical Limb Ischemia: Current Trends and Future Directions"
3774:
3104:
3063:
772:
If ABIs are abnormal, the next step is generally a lower limb
712:
These findings are associated with peripheral artery disease:
700:
5119:
4968:"Epidemiology of Peripheral Artery Disease: Narrative Review"
4431:
4192:
4069:
4025:
3420:
Serrano Hernando FJ, Martín Conejero A (September 2007). "".
3145:
797:
789:
250:
246:
4739:
3930:
3180:
1654:
6100:
5390:
5341:
5164:
5068:
4385:"Management of peripheral arterial disease in primary care"
3579:
3554:
1168:
1081:
not well established. Research also suggests that low-dose
284:
280:
5467:
3862:
3557:
Rosen's Emergency Medicine: Concepts and Clinical Practice
3385:
3350:
3315:
4151:
3730:
3652:
2185:
U.S. Preventive Services Task Force (December 15, 2014).
1182:
may be required to prevent infected tissues from causing
1107:, a putative vascular risk factor, are near completion".
1018:
helps open up alternative small vessels (collateral flow)
456:
Pain, aches, and/or cramps in the buttocks, hip, or thigh
3972:
Teraa M, Conte MS, Moll FL, Verhaar MC (February 2016).
1163:
is used as a conduit if available, although artificial (
271:
Peripheral artery disease (PAD) is a form of peripheral
5471:
Journal of Cardiovascular Pharmacology and Therapeutics
4965:
3687:
2569:
Papadakis MA, McPhee SJ, Rabow RW (September 7, 2018).
2265:
1576:
978:
of PAD patients, in a goal to improve health outcomes.
627:
Those with known atherosclerotic coronary, carotid, or
5256:
4815:
4305:. Adv Exp Med Biol. Vol. 1072. pp. 351–356.
3555:
Walls R, Hockberger R, Gausche-Hill M (May 18, 2017).
2971:
2935:
2807:"Supporting Family Physician Maternity Care Providers"
2748:
2371:
2057:(20 ed.). McGraw-Hill Education / Medical. 2018.
1877:
1375:
264:. Peripheral artery disease most commonly affects the
3971:
3869:
European Journal of Vascular and Endovascular Surgery
3322:
European Journal of Vascular and Endovascular Surgery
2853:
2692:
2376:(2nd ed.). Philadelphia, PA: Elsevier/Saunders.
1787:
641:
All people who have previously experienced chest pain
318:. Up to 50% of people with PAD do not have symptoms.
5714:
5570:
4690:
4110:
3500:
2615:
2568:
4650:
The International Journal of Lower Extremity Wounds
3734:
The International Journal of Cardiovascular Imaging
3267:
1825:
5524:at the American College of Foot and Ankle Surgeons
4916:
4382:
3467:
2688:
2686:
1961:"Arterial Diseases of the Extremities Chapter 275"
1959:
474:Sores/ulcers on the affected limb that do not heal
2967:
2965:
2963:
2961:
2959:
859:The Rutherford classification was created by the
604:All people aged 65 years and over, regardless of
459:Muscle atrophy (muscle loss) of the affected limb
256:When narrowing occurs in the heart, it is called
64:in a person with severe peripheral artery disease
6481:Diseases of arteries, arterioles and capillaries
6472:
5113:
4858:
4371:
3904:Fontaine R, Kim M, Kieny R (December 1954). "".
3903:
2894:
2804:
2131:
2129:
1025:the maximum walking distance in people with PAD.
5518:at the National Heart, Lung and Blood Institute
4867:
4865:
4863:
4861:
4691:Chowdhury MM, McLain AD, Twine CP (June 2014).
4523:
4378:
4376:
4374:
3476:, Treasure Island (FL): StatPearls Publishing,
2683:
2680:Professional Edition. Retrieved August 9, 2010.
2515:, Treasure Island (FL): StatPearls Publishing,
2309:
2014:, Treasure Island (FL): StatPearls Publishing,
1957:
1625:"How Is Peripheral Arterial Disease Diagnosed?"
780:, where a catheter is inserted into the common
645:
5027:
4477:"Pentoxifylline for intermittent claudication"
2956:
2895:Smith GD, Shipley MJ, Rose G (December 1990).
2571:Current medical diagnosis & treatment 2019
970:Wearable devices and remote patient monitoring
5700:
4822:Journal of the American College of Cardiology
4742:"Atherectomy for peripheral arterial disease"
3965:
3501:Krishna SM, Moxon JV, Golledge J (May 2015).
2978:Journal of the American College of Cardiology
2545:"Peripheral Arterial Disease (PAD) | cdc.gov"
2506:
2126:
2100:Journal of the American College of Cardiology
2098:Task Force on Clinical Practice Guidelines".
1821:
1819:
1700:"How Is Peripheral Arterial Disease Treated?"
1619:
1617:
1016:Regular exercise for those with claudication
621:Individuals with an abnormal lower extremity
384:may improve outcomes. Medications, including
91:Leg pain when walking that resolves with rest
4383:Burns P, Gough S, Bradbury AW (March 2003).
3628:
2805:Avery DM, Skinner CA, Reed MD (April 2019).
2749:Elsevier Point of Care (December 11, 2018).
2135:
1873:
1871:
1694:
1692:
1655:Ruiz-Canela M, Martínez-González MA (2014).
1572:
1570:
1568:
1566:
1564:
1415:
1413:
1303:of autologous mononuclear cells is unclear.
5214:The Cochrane Database of Systematic Reviews
4746:The Cochrane Database of Systematic Reviews
4697:The Cochrane Database of Systematic Reviews
4526:The Cochrane Database of Systematic Reviews
4481:The Cochrane Database of Systematic Reviews
4251:
3507:International Journal of Molecular Sciences
3224:
3020:
2751:"Atherosclerotic peripheral artery disease"
2616:Sahu A, Sagar R, Sarkar S, Sagar S (2016).
2372:Creager MA, Beckman JA, Loscalzo J (2013).
2223:The Cochrane Database of Systematic Reviews
2142:The Cochrane Database of Systematic Reviews
2138:"Screening for peripheral arterial disease"
1783:
1781:
1779:
1777:
1738:The Cochrane Database of Systematic Reviews
1533:
1531:
1491:
1489:
1487:
357:. PAD is typically diagnosed by finding an
6280:Chronic cerebrospinal venous insufficiency
5707:
5693:
4584:|...|intentional=yes}}
3227:Journal of the American Geriatrics Society
2601:: CS1 maint: location missing publisher (
2549:Centers for Disease Control and Prevention
2219:"Cilostazol for intermittent claudication"
2092:
2090:
2088:
2086:
2084:
2082:
2080:
2078:
2076:
2074:
2055:Harrison's principles of internal medicine
2049:
2047:
2045:
2043:
2041:
2039:
2037:
2035:
1966:Harrison's Principles of Internal Medicine
1816:
1727:
1725:
1614:
1539:"What Causes Peripheral Arterial Disease?"
1456:
1454:
1452:
1450:
1448:
1446:
916:Grade 1: small, shallow ulcer; no gangrene
877:Grade I, Category 2: moderate claudication
51:
5553:
5418:
5408:
5367:
5348:Journal of the American Heart Association
5318:
5233:
5137:
5096:
5086:
5045:
5001:
4991:
4922:
4899:
4889:
4841:
4765:
4716:
4624:
4500:
4408:
4328:
4277:
4228:
4210:
4169:
4128:
4087:
4043:
3997:
3978:Journal of the American Heart Association
3948:
3880:
3828:
3597:
3528:
3518:
3368:
3333:
3122:
3081:
2997:
2912:
2871:
2822:
2718:
2677:The Merck Manual of Diagnosis and Therapy
2643:
2633:
2480:
2470:
2429:
2242:
2161:
2005:
1990:
1903:
1868:
1851:
1757:
1689:
1672:
1561:
1410:
1371:
1369:
1367:
1355:
661:As previously mentioned, the most common
4647:
3468:Zemaitis MR, Boll JM, Dreyer MA (2023),
3308:
3306:
3304:
3302:
3300:
2800:
2798:
2796:
2667:
2665:
2663:
2573:(Fifty-eighth ed.). New York, N.Y.
1774:
1650:
1648:
1646:
1528:
1484:
1123:
880:Grade I, Category 3: severe claudication
817:
699:
649:
592:
518:
431:
5023:
5021:
4871:
4300:
4065:
4063:
2538:
2536:
2398:
2312:VASA. Zeitschrift für Gefässkrankheiten
2281:10.7326/0003-4819-159-5-201309030-00007
2071:
2032:
1920:
1722:
1443:
14:
6473:
5449:from the original on September 3, 2015
4796:
3810:
3622:
2452:
1710:from the original on February 25, 2015
1549:from the original on February 25, 2015
1504:American Heart Association (heart.org)
1497:"What Is Peripheral Vascular Disease?"
1472:from the original on February 25, 2015
1462:"What Is Peripheral Arterial Disease?"
1431:from the original on February 25, 2015
1364:
905:evolving techniques and abilities for
874:Grade I, Category 1: mild claudication
260:(CAD), and in the brain, it is called
6052:Hereditary hemorrhagic telangiectasia
5688:
5300:
5294:
5250:
5028:Selvin E, Erlinger TP (August 2004).
4021:
4019:
4017:
3858:
3856:
3550:
3548:
3463:
3461:
3459:
3415:
3413:
3297:
2793:
2744:
2742:
2740:
2738:
2660:
2502:
2500:
2212:
2210:
2208:
1953:
1951:
1643:
1341:
1091:can improve symptoms in some people.
468:Decreased or absent pulse in the feet
427:
6057:Generalized essential telangiectasia
5522:Peripheral Arterial Disease (P.A.D.)
5018:
4925:British Journal of Hospital Medicine
4060:
3817:Topics in Magnetic Resonance Imaging
2780:The Lecturio Medical Concept Library
2533:
2344:
2201:from the original on March 31, 2017.
1878:Wang H, et al. (October 2016).
1233:or less or those who do not have an
1110:
982:requires a physiological challenge.
683:Other causes include vasculitis and
321:The greatest risk factor for PAD is
5154:from the original on March 4, 2012.
4878:Vascular Health and Risk Management
2542:
1513:from the original on April 12, 2015
361:(ABI) less than 0.90, which is the
24:
5139:10.2337/diacare.29.04.06.dc05-2018
5047:10.1161/01.CIR.0000137913.26087.F0
4014:
3853:
3830:10.1097/01.rmr.0000185431.50535.d7
3545:
3456:
3410:
3239:10.1111/j.1532-5415.1985.tb02853.x
3124:10.1161/01.cir.0000089189.70578.e2
3083:10.1161/01.cir.0000091257.27563.32
2735:
2497:
2205:
1948:
1631:from the original on April 7, 2015
735:Smooth or shiny skin and hair loss
704:Measuring the ankle-brachial index
241:that causes abnormal narrowing of
25:
6497:
5509:
3641:from the original on May 9, 2008.
3629:Vowden P, Vowden K (March 2001).
2136:Andras A, Ferket B (April 2014).
1241:, bypass surgery is recommended.
871:Grade 0, Category 0: asymptomatic
813:
245:other than those that supply the
6207:Cerebral venous sinus thrombosis
4617:10.1097/00000658-198710000-00002
749:Nonhealing lower extremity wound
471:Cold and/or numbness in the toes
5461:
5443:"Gene Therapy for PAD Approved"
5435:
5384:
5335:
5201:
5158:
5062:
4959:
4809:
4797:Health Cf (February 26, 2021).
4790:
4733:
4684:
4641:
4592:
4517:
4468:
4425:
4345:
4294:
4245:
4186:
4145:
4104:
3924:
3897:
3804:
3768:
3724:
3681:
3646:
3573:
3494:
3422:Revista Espanola de Cardiologia
3261:
3218:
3174:
3139:
3098:
3057:
3014:
2929:
2888:
2847:
2768:
2609:
2562:
2446:
2416:(9963): 117–171. January 2015.
2365:
2338:
2303:
2259:
2178:
1999:
1984:
1958:Creager MA, Loscalzo J (2018).
1257:
883:Grade II, Category 4: rest pain
514:
6158:Hepatic veno-occlusive disease
5226:10.1002/14651858.CD008347.pub4
4758:10.1002/14651858.CD006680.pub3
4709:10.1002/14651858.CD006767.pub3
4553:10.1002/14651858.CD000017.pub2
4493:10.1002/14651858.CD005262.pub4
2944:(4): 753–6, discussion 756–7.
2507:Patel SK, Surowiec SM (2023),
2235:10.1002/14651858.CD003748.pub5
2154:10.1002/14651858.CD010835.pub2
1932:Merck Manuals Consumer Version
1750:10.1002/14651858.CD005263.pub4
1335:
1226:American College of Cardiology
1046:Management of high cholesterol
913:Grade 0: no ulcer, no gangrene
808:Magnetic resonance angiography
462:Hair loss of the affected limb
13:
1:
5970:Aneurysm of sinus of Valsalva
5824:Monckeberg's arteriosclerosis
5516:"Peripheral Arterial Disease"
5272:10.1016/S0140-6736(05)67704-5
4434:Current Opinion in Cardiology
4303:Oxygen Transport to Tissue XL
3950:10.1016/S0741-5214(97)70045-4
3470:"Peripheral Arterial Disease"
3196:10.1016/s0140-6736(05)67394-1
2622:Industrial Psychiatry Journal
2422:10.1016/S0140-6736(14)61682-2
2008:"Peripheral Vascular Disease"
1896:10.1016/s0140-6736(16)31012-1
1844:10.1016/S0140-6736(16)31678-6
1592:10.1016/s0140-6736(13)61249-0
1342:Moore J (September 1, 2008).
1328:
1219:
1186:, a life-threatening illness.
1029:
496:arterial insufficiency ulcers
325:. Other risk factors include
6275:Chronic venous insufficiency
5900:Aortoiliac occlusive disease
5546:10.1161/CIR.0000000000000470
4931:(3). Mark Allen Group: 1–9.
4446:10.1097/HCO.0000000000000597
4311:10.1007/978-3-319-91287-5_56
3599:10.1161/CIR.0b013e318276fbcb
1980:– via Access Medicine.
1386:10.1007/978-3-642-29423-5_22
1348:The Foot & Ankle Journal
1244:
1213:Food and Drug Administration
1007:
999:
950:
902:Society for Vascular Surgery
861:Society for Vascular Surgery
695:
646:Etiology and pathophysiology
452:Other symptoms may include:
62:arterial insufficiency ulcer
7:
6290:Inferior vena cava syndrome
6285:Superior vena cava syndrome
6012:Vertebral artery dissection
6002:Intracranial berry aneurysm
5307:Journal of Vascular Surgery
5075:Cardiovascular Therapeutics
4258:Curr Cardiovasc Imaging Rep
4252:Lopez D, Kramer CM (2013).
4158:Journal of Vascular Surgery
4076:Journal of Vascular Surgery
4032:Journal of Vascular Surgery
3937:Journal of Vascular Surgery
3357:Journal of Vascular Surgery
2824:10.22454/fammed.2019.636289
2776:"Peripheral Artery Disease"
2672:Peripheral Arterial Disease
2509:"Intermittent Claudication"
2269:Annals of Internal Medicine
1357:10.3827/faoj.2008.0109.0002
1308:randomized controlled trial
1294:
18:Peripheral arterial disease
10:
6502:
6391:Hypertensive heart disease
6042:Arteriovenous malformation
6017:Familial aortic dissection
4834:10.1016/j.jacc.2011.08.023
3882:10.1016/j.ejvs.2006.09.024
3811:Leiner T (February 2005).
3746:10.1007/s10554-021-02277-1
3667:10.1016/j.avsg.2013.01.006
3655:Annals of Vascular Surgery
3335:10.1016/j.ejvs.2006.09.024
2990:10.1016/j.jacc.2013.01.004
2543:CDC (September 27, 2021).
2112:10.1016/j.jacc.2016.11.008
1230:American Heart Association
1041:Management of hypertension
964:abdominal aortic aneurysms
716:Decreased or absent pulses
582:abdominal aortic aneurysms
535:dose-response relationship
6486:Health effects of tobacco
6446:
6416:Renovascular hypertension
6381:
6372:
6359:Hepatic artery thrombosis
6307:
6267:
6222:
6126:
6108:
6099:
6067:
6027:
6007:Carotid artery dissection
5960:Abdominal aortic aneurysm
5932:
5892:
5869:
5810:Intermittent claudication
5780:
5773:Peripheral artery disease
5771:
5741:
5723:
5644:
5574:
5410:10.1186/s13063-015-1114-2
5320:10.1016/j.jvs.2010.02.001
4891:10.2147/vhrm.2007.3.2.229
4534:10.1002/14651858.CD000017
4270:10.1007/s12410-013-9191-7
4171:10.1016/j.jvs.2014.12.008
4089:10.1016/j.jvs.2013.08.003
4045:10.1016/j.jvs.2013.08.003
3906:Helvetica Chirurgica Acta
3790:10.1148/radiol.2352040089
3370:10.1016/j.jvs.2006.12.037
2472:10.1186/s40779-016-0094-1
2459:Military Medical Research
2347:American Family Physician
2324:10.1024/0301-1526/a000251
2006:Gul F, Janzer SD (2023),
976:remote patient monitoring
719:Muscle atrophy or wasting
552:High blood cholesterol –
509:
443:intermittent claudication
404:(blood thinners) such as
294:. Other symptoms include
292:intermittent claudication
231:Peripheral artery disease
220:
212:
192:
177:
157:
132:
118:
105:
84:
68:
59:
50:
42:
38:Peripheral artery disease
37:
6401:Hypertensive nephropathy
6214:Post-thrombotic syndrome
6195:Paget–Schroetter disease
5987:Coronary artery aneurysm
5965:Thoracic aortic aneurysm
5483:10.1177/1074248415574336
4662:10.1177/1534734605283538
4401:10.1136/bmj.326.7389.584
3283:10.1001/jama.285.19.2481
2914:10.1161/01.cir.82.6.1925
2635:10.4103/0972-6748.196041
1674:10.1253/circj.cj-14-0062
1207:shockwave intravascular
759:noncompressible arteries
566:high-density lipoprotein
75:Interventional radiology
6456:Orthostatic hypotension
6438:White coat hypertension
5915:Fibromuscular dysplasia
5879:Carotid artery stenosis
5360:10.1161/JAHA.116.003219
4937:10.12968/hmed.2019.0263
4212:10.3390/ijerph192215231
3990:10.1161/JAHA.115.002938
3392:International Angiology
3035:10.2337/diacare.2.2.120
2711:10.1001/jama.2012.13415
802:computerized tomography
746:tissue that it goes to.
558:low-density lipoprotein
524:of the narrowed artery.
363:systolic blood pressure
351:fibromuscular dysplasia
333:, kidney problems, and
312:coronary artery disease
262:cerebrovascular disease
258:coronary artery disease
6428:Pulmonary hypertension
6411:Secondary hypertension
6406:Essential hypertension
6396:Hypertensive emergency
6237:Portacaval anastomosis
6173:Portal vein thrombosis
5815:Critical limb ischemia
5716:Cardiovascular disease
4130:10.1001/jama.2018.8357
3702:10.1001/jama.301.4.415
2873:10.1053/euhj.1998.1194
2860:European Heart Journal
1802:10.1001/jama.295.5.547
1129:
1036:Management of diabetes
895:critical limb ischemia
823:
705:
655:
576:High blood pressure –
525:
480:critical limb ischemia
437:
367:Duplex ultrasonography
335:high blood cholesterol
168:duplex ultrasonography
151:high blood cholesterol
6433:Systolic hypertension
6178:Renal vein thrombosis
6037:Arteriovenous fistula
6029:Vascular malformation
5997:Intracranial aneurysm
5884:Renal artery stenosis
5301:Conte MS (May 2010).
5167:Hypertension Research
4576:|...}}
4547:(Retracted, see
3520:10.3390/ijms160511294
3160:10.1007/s001250050257
1224:A guideline from the
1196:are used in cases of
1143:the narrowing of the
1127:
1022:limitation in walking
835:Stage I: asymptomatic
821:
703:
653:
636:Framingham risk score
593:High risk populations
522:
435:
6347:Paradoxical embolism
6342:Cholesterol embolism
6168:May–Thurner syndrome
6163:Budd–Chiari syndrome
6146:Deep vein thrombosis
6141:primarily lower limb
5920:Raynaud's phenomenon
5445:. December 6, 2011.
5313:(5 Suppl): 69S–75S.
5088:10.1155/2019/8295054
4993:10.3390/life12071041
4164:(3 Suppl): 42S–53S.
1890:(10053): 1459–1544.
1838:(10053): 1545–1602.
1161:great saphenous vein
1105:hyperhomocysteinemia
957:ankle-brachial index
865:Robert B. Rutherford
844:Stage III: rest pain
755:ankle–brachial index
726:of the affected limb
616:hyperhomocysteinemia
500:erectile dysfunction
359:ankle-brachial index
306:, which may require
164:Ankle-brachial index
6423:Benign hypertension
5266:(9501): 1925–1934.
5179:10.1038/hr.2015.134
4984:2022Life...12.1041H
4872:Shammas NW (2007).
4038:(1): 220–234.e1–2.
3190:(9493): 1267–1278.
1661:Circulation Journal
1586:(9901): 1329–1340.
1378:Antiplatelet Agents
1301:autotransplantation
1198:arterial thrombosis
1145:subsartorial artery
788:contrast agent, an
544:High blood sugar –
331:high blood pressure
147:high blood pressure
6337:Pulmonary embolism
6247:Esophageal varices
6185:upper limb / torso
5829:Arteriolosclerosis
5645:External resources
4357:www.prnewswire.com
4082:(1): 220–34.e1–2.
3875:(Suppl 1): S1-75.
3513:(5): 11294–11322.
3363:(Suppl S): S5-67.
3328:(Suppl 1): S1-75.
3312:TASC II Guidelines
2453:Münter KC (2016).
1706:. August 2, 2011.
1627:. August 2, 2011.
1545:. August 2, 2011.
1468:. August 2, 2011.
1427:. August 2, 2011.
1130:
1072:("heart attack"),
1050:antiplatelet drugs
824:
796:, angioplasty, or
774:Doppler ultrasound
706:
656:
634:All people with a
526:
438:
428:Signs and symptoms
216:155 million (2015)
6468:
6467:
6464:
6463:
6308:Arteries or veins
6303:
6302:
6128:Venous thrombosis
6095:
6094:
6077:Cherry hemangioma
5977:Aortic dissection
5928:
5927:
5763:Buerger's disease
5682:
5681:
5540:(12): e686–e725.
4828:(19): 2020–2045.
4605:Annals of Surgery
4395:(7389): 584–588.
4320:978-3-319-91285-1
3740:(10): 3101–3114.
3592:(24): 2890–2909.
3277:(19): 2481–2485.
3117:(13): 1655–1661.
3076:(12): 1527–1532.
2984:(14): 1555–1570.
2705:(16): 1660–1667.
2353:(10): 1000–1001.
2197:(12): 858A–858D.
2106:(11): 1465–1508.
1395:978-3-642-29422-8
1316:clinical endpoint
1273:Mexican Americans
1117:revascularization
1111:Revascularization
907:revascularization
623:pulse examination
564:), low levels of
546:Diabetes mellitus
396:, may also help.
376:It is unclear if
323:cigarette smoking
239:vascular disorder
228:
227:
159:Diagnostic method
139:Cigarette smoking
32:Medical condition
16:(Redirected from
6493:
6379:
6378:
6190:Mondor's disease
6133:Thrombophlebitis
6106:
6105:
5782:Arteriosclerosis
5778:
5777:
5739:
5738:
5709:
5702:
5695:
5686:
5685:
5572:
5571:
5567:
5557:
5503:
5502:
5465:
5459:
5458:
5456:
5454:
5439:
5433:
5432:
5422:
5412:
5388:
5382:
5381:
5371:
5339:
5333:
5332:
5322:
5298:
5292:
5291:
5254:
5248:
5247:
5237:
5205:
5199:
5198:
5162:
5156:
5155:
5141:
5117:
5111:
5110:
5100:
5090:
5066:
5060:
5059:
5049:
5025:
5016:
5015:
5005:
4995:
4963:
4957:
4956:
4920:
4914:
4913:
4903:
4893:
4869:
4856:
4855:
4845:
4813:
4807:
4806:
4794:
4788:
4787:
4769:
4737:
4731:
4730:
4720:
4688:
4682:
4681:
4645:
4639:
4638:
4628:
4596:
4590:
4589:
4587:
4585:
4577:
4566:Retraction Watch
4545:
4521:
4515:
4514:
4504:
4487:(10): CD005262.
4472:
4466:
4465:
4429:
4423:
4422:
4412:
4380:
4369:
4368:
4366:
4364:
4349:
4343:
4342:
4332:
4298:
4292:
4291:
4281:
4249:
4243:
4242:
4232:
4214:
4190:
4184:
4183:
4173:
4149:
4143:
4142:
4132:
4108:
4102:
4101:
4091:
4067:
4058:
4057:
4047:
4023:
4012:
4011:
4001:
3969:
3963:
3962:
3952:
3928:
3922:
3921:
3912:(5–6): 499–533.
3901:
3895:
3894:
3884:
3860:
3851:
3850:
3832:
3808:
3802:
3801:
3772:
3766:
3765:
3728:
3722:
3721:
3685:
3679:
3678:
3650:
3644:
3642:
3635:Worldwide Wounds
3626:
3620:
3619:
3601:
3577:
3571:
3570:
3552:
3543:
3542:
3532:
3522:
3498:
3492:
3491:
3490:
3488:
3465:
3454:
3453:
3434:10.1157/13109651
3417:
3408:
3407:
3382:
3372:
3347:
3337:
3310:
3295:
3294:
3265:
3259:
3258:
3222:
3216:
3215:
3178:
3172:
3171:
3143:
3137:
3136:
3126:
3102:
3096:
3095:
3085:
3061:
3055:
3054:
3018:
3012:
3011:
3001:
2969:
2954:
2953:
2933:
2927:
2926:
2916:
2907:(6): 1925–1931.
2892:
2886:
2885:
2875:
2851:
2845:
2844:
2826:
2802:
2791:
2790:
2788:
2786:
2772:
2766:
2765:
2763:
2761:
2746:
2733:
2732:
2722:
2690:
2681:
2669:
2658:
2657:
2647:
2637:
2613:
2607:
2606:
2600:
2592:
2566:
2560:
2559:
2557:
2555:
2540:
2531:
2530:
2529:
2527:
2504:
2495:
2494:
2484:
2474:
2450:
2444:
2443:
2433:
2402:
2396:
2395:
2369:
2363:
2362:
2342:
2336:
2335:
2307:
2301:
2300:
2263:
2257:
2256:
2246:
2214:
2203:
2202:
2191:Am Fam Physician
2182:
2176:
2175:
2165:
2133:
2124:
2123:
2094:
2069:
2068:
2051:
2030:
2029:
2028:
2026:
2003:
1997:
1996:
1988:
1982:
1981:
1979:
1977:
1963:
1955:
1946:
1945:
1940:
1938:
1924:
1918:
1917:
1907:
1875:
1866:
1865:
1855:
1823:
1814:
1813:
1785:
1772:
1771:
1761:
1729:
1720:
1719:
1717:
1715:
1696:
1687:
1686:
1676:
1652:
1641:
1640:
1638:
1636:
1621:
1612:
1611:
1574:
1559:
1558:
1556:
1554:
1535:
1526:
1525:
1520:
1518:
1512:
1501:
1493:
1482:
1481:
1479:
1477:
1458:
1441:
1440:
1438:
1436:
1417:
1408:
1407:
1373:
1362:
1361:
1359:
1339:
987:such as through
382:exercise therapy
186:exercise therapy
182:Stopping smoking
79:vascular surgery
55:
35:
34:
21:
6501:
6500:
6496:
6495:
6494:
6492:
6491:
6490:
6471:
6470:
6469:
6460:
6442:
6368:
6325:Microangiopathy
6320:Macroangiopathy
6299:
6263:
6232:Gastric varices
6218:
6131:
6122:
6091:
6063:
6023:
5955:Aortic aneurysm
5941:
5924:
5910:Erythromelalgia
5888:
5865:
5790:Atherosclerosis
5767:
5731:
5719:
5713:
5683:
5678:
5677:
5640:
5639:
5583:
5512:
5507:
5506:
5466:
5462:
5452:
5450:
5441:
5440:
5436:
5389:
5385:
5340:
5336:
5299:
5295:
5255:
5251:
5220:(7): CD008347.
5206:
5202:
5163:
5159:
5118:
5114:
5067:
5063:
5026:
5019:
4964:
4960:
4921:
4917:
4870:
4859:
4814:
4810:
4795:
4791:
4752:(9): CD006680.
4738:
4734:
4703:(6): CD006767.
4689:
4685:
4646:
4642:
4597:
4593:
4579:
4571:
4569:
4546:
4528:(2): CD000017.
4522:
4518:
4473:
4469:
4430:
4426:
4381:
4372:
4362:
4360:
4359:(Press release)
4351:
4350:
4346:
4321:
4299:
4295:
4250:
4246:
4191:
4187:
4150:
4146:
4109:
4105:
4068:
4061:
4024:
4015:
3970:
3966:
3929:
3925:
3902:
3898:
3861:
3854:
3809:
3805:
3773:
3769:
3729:
3725:
3686:
3682:
3651:
3647:
3627:
3623:
3578:
3574:
3567:
3553:
3546:
3499:
3495:
3486:
3484:
3466:
3457:
3418:
3411:
3383:
3348:
3313:
3311:
3298:
3266:
3262:
3223:
3219:
3179:
3175:
3144:
3140:
3103:
3099:
3062:
3058:
3019:
3015:
2970:
2957:
2934:
2930:
2893:
2889:
2852:
2848:
2811:Family Medicine
2803:
2794:
2784:
2782:
2774:
2773:
2769:
2759:
2757:
2747:
2736:
2691:
2684:
2670:
2661:
2614:
2610:
2594:
2593:
2581:
2567:
2563:
2553:
2551:
2541:
2534:
2525:
2523:
2505:
2498:
2451:
2447:
2404:
2403:
2399:
2384:
2370:
2366:
2343:
2339:
2308:
2304:
2264:
2260:
2229:(6): CD003748.
2215:
2206:
2183:
2179:
2148:(4): CD010835.
2134:
2127:
2095:
2072:
2065:
2053:
2052:
2033:
2024:
2022:
2004:
2000:
1993:Atherosclerosis
1989:
1985:
1975:
1973:
1956:
1949:
1936:
1934:
1926:
1925:
1921:
1876:
1869:
1824:
1817:
1786:
1775:
1744:(4): CD005263.
1730:
1723:
1713:
1711:
1698:
1697:
1690:
1653:
1644:
1634:
1632:
1623:
1622:
1615:
1575:
1562:
1552:
1550:
1537:
1536:
1529:
1516:
1514:
1510:
1499:
1495:
1494:
1485:
1475:
1473:
1460:
1459:
1444:
1434:
1432:
1419:
1418:
1411:
1396:
1374:
1365:
1340:
1336:
1331:
1297:
1260:
1247:
1239:autogenous vein
1235:autogenous vein
1222:
1157:Vascular bypass
1113:
1102:
1032:
1010:
1002:
984:Pulse oximeters
972:
953:
816:
763:false negatives
732:Thickened nails
698:
648:
595:
517:
512:
430:
410:bypass grafting
339:atherosclerosis
123:Atherosclerosis
33:
28:
23:
22:
15:
12:
11:
5:
6499:
6489:
6488:
6483:
6466:
6465:
6462:
6461:
6459:
6458:
6452:
6450:
6444:
6443:
6441:
6440:
6435:
6430:
6425:
6420:
6419:
6418:
6408:
6403:
6398:
6393:
6387:
6385:
6376:
6374:Blood pressure
6370:
6369:
6367:
6366:
6361:
6356:
6351:
6350:
6349:
6344:
6339:
6329:
6328:
6327:
6322:
6311:
6309:
6305:
6304:
6301:
6300:
6298:
6297:
6292:
6287:
6282:
6277:
6271:
6269:
6265:
6264:
6262:
6261:
6256:
6255:
6254:
6249:
6244:
6234:
6228:
6226:
6224:Varicose veins
6220:
6219:
6217:
6216:
6211:
6210:
6209:
6199:
6198:
6197:
6192:
6182:
6181:
6180:
6175:
6170:
6165:
6160:
6150:
6149:
6148:
6137:
6135:
6124:
6123:
6121:
6120:
6114:
6112:
6103:
6097:
6096:
6093:
6092:
6090:
6089:
6087:Spider angioma
6084:
6079:
6073:
6071:
6069:Vascular nevus
6065:
6064:
6062:
6061:
6060:
6059:
6054:
6047:Telangiectasia
6044:
6039:
6033:
6031:
6025:
6024:
6022:
6021:
6020:
6019:
6014:
6009:
6004:
5999:
5989:
5984:
5982:Aortic rupture
5979:
5974:
5973:
5972:
5967:
5962:
5947:
5945:
5943:pseudoaneurysm
5930:
5929:
5926:
5925:
5923:
5922:
5917:
5912:
5907:
5902:
5896:
5894:
5890:
5889:
5887:
5886:
5881:
5875:
5873:
5867:
5866:
5864:
5863:
5862:
5861:
5856:
5854:Oxycholesterol
5851:
5846:
5841:
5836:
5826:
5820:
5819:
5818:
5817:
5812:
5807:
5802:
5797:
5786:
5784:
5775:
5769:
5768:
5766:
5765:
5760:
5759:
5758:
5747:
5745:
5736:
5721:
5720:
5712:
5711:
5704:
5697:
5689:
5680:
5679:
5676:
5675:
5661:
5649:
5648:
5646:
5642:
5641:
5638:
5637:
5626:
5615:
5600:
5584:
5579:
5578:
5576:
5575:Classification
5569:
5568:
5525:
5519:
5511:
5510:External links
5508:
5505:
5504:
5477:(5): 473–482.
5460:
5434:
5383:
5354:(7): e003219.
5334:
5293:
5249:
5200:
5173:(4): 183–191.
5157:
5132:(4): 877–882.
5112:
5061:
5040:(6): 738–743.
5017:
4958:
4915:
4884:(2): 229–234.
4857:
4808:
4789:
4732:
4683:
4656:(4): 234–241.
4640:
4611:(4): 403–413.
4591:
4516:
4467:
4440:(2): 178–184.
4424:
4370:
4344:
4319:
4293:
4244:
4185:
4144:
4123:(2): 177–183.
4103:
4059:
4013:
3984:(2): e002938.
3964:
3943:(3): 517–538.
3923:
3896:
3852:
3803:
3784:(2): 699–708.
3767:
3723:
3696:(4): 415–424.
3680:
3661:(7): 918–923.
3645:
3621:
3572:
3565:
3544:
3493:
3455:
3428:(9): 969–982.
3409:
3296:
3260:
3217:
3173:
3138:
3097:
3056:
3029:(2): 120–126.
3013:
2955:
2928:
2887:
2866:(5): 344–353.
2846:
2792:
2767:
2734:
2682:
2659:
2608:
2579:
2561:
2532:
2496:
2445:
2397:
2382:
2364:
2337:
2302:
2275:(5): 333–341.
2258:
2204:
2177:
2125:
2070:
2063:
2031:
1998:
1983:
1947:
1919:
1867:
1815:
1796:(5): 547–553.
1773:
1721:
1688:
1667:(3): 553–559.
1642:
1613:
1560:
1527:
1483:
1442:
1409:
1394:
1363:
1333:
1332:
1330:
1327:
1296:
1293:
1259:
1256:
1246:
1243:
1221:
1218:
1217:
1216:
1205:
1187:
1172:
1154:
1148:
1140:iliac arteries
1136:femoral artery
1112:
1109:
1100:
1093:Pentoxifylline
1066:
1065:
1043:
1038:
1031:
1028:
1027:
1026:
1014:
1009:
1006:
1001:
998:
993:subcutaneously
989:transcutaneous
971:
968:
952:
949:
941:
940:
937:
934:
931:
924:
923:
920:
917:
914:
900:Recently, the
891:
890:
887:
884:
881:
878:
875:
872:
857:
856:
845:
842:
839:
836:
815:
814:Classification
812:
782:femoral artery
751:
750:
747:
741:can check for
739:Buerger's test
736:
733:
730:
727:
720:
717:
697:
694:
647:
644:
643:
642:
639:
632:
625:
619:
612:
609:
602:
594:
591:
590:
589:
585:
574:
550:
542:
516:
513:
511:
508:
494:(amputation),
476:
475:
472:
469:
466:
463:
460:
457:
429:
426:
402:Anticoagulants
390:ACE inhibitors
226:
225:
222:
218:
217:
214:
210:
209:
203:ACE inhibitors
196:
190:
189:
179:
175:
174:
161:
155:
154:
136:
130:
129:
120:
116:
115:
109:
103:
102:
88:
82:
81:
72:
66:
65:
57:
56:
48:
47:
44:
40:
39:
31:
26:
9:
6:
4:
3:
2:
6498:
6487:
6484:
6482:
6479:
6478:
6476:
6457:
6454:
6453:
6451:
6449:
6445:
6439:
6436:
6434:
6431:
6429:
6426:
6424:
6421:
6417:
6414:
6413:
6412:
6409:
6407:
6404:
6402:
6399:
6397:
6394:
6392:
6389:
6388:
6386:
6384:
6380:
6377:
6375:
6371:
6365:
6362:
6360:
6357:
6355:
6352:
6348:
6345:
6343:
6340:
6338:
6335:
6334:
6333:
6330:
6326:
6323:
6321:
6318:
6317:
6316:
6313:
6312:
6310:
6306:
6296:
6293:
6291:
6288:
6286:
6283:
6281:
6278:
6276:
6273:
6272:
6270:
6266:
6260:
6257:
6253:
6250:
6248:
6245:
6243:
6242:Caput medusae
6240:
6239:
6238:
6235:
6233:
6230:
6229:
6227:
6225:
6221:
6215:
6212:
6208:
6205:
6204:
6203:
6200:
6196:
6193:
6191:
6188:
6187:
6186:
6183:
6179:
6176:
6174:
6171:
6169:
6166:
6164:
6161:
6159:
6156:
6155:
6154:
6151:
6147:
6144:
6143:
6142:
6139:
6138:
6136:
6134:
6129:
6125:
6119:
6116:
6115:
6113:
6111:
6107:
6104:
6102:
6098:
6088:
6085:
6083:
6080:
6078:
6075:
6074:
6072:
6070:
6066:
6058:
6055:
6053:
6050:
6049:
6048:
6045:
6043:
6040:
6038:
6035:
6034:
6032:
6030:
6026:
6018:
6015:
6013:
6010:
6008:
6005:
6003:
6000:
5998:
5995:
5994:
5993:
5990:
5988:
5985:
5983:
5980:
5978:
5975:
5971:
5968:
5966:
5963:
5961:
5958:
5957:
5956:
5952:
5949:
5948:
5946:
5944:
5939:
5935:
5931:
5921:
5918:
5916:
5913:
5911:
5908:
5906:
5905:Degos disease
5903:
5901:
5898:
5897:
5895:
5891:
5885:
5882:
5880:
5877:
5876:
5874:
5872:
5868:
5860:
5857:
5855:
5852:
5850:
5847:
5845:
5842:
5840:
5837:
5835:
5832:
5831:
5830:
5827:
5825:
5822:
5821:
5816:
5813:
5811:
5808:
5806:
5803:
5801:
5798:
5796:
5793:
5792:
5791:
5788:
5787:
5785:
5783:
5779:
5776:
5774:
5770:
5764:
5761:
5757:
5754:
5753:
5752:
5749:
5748:
5746:
5744:
5740:
5737:
5735:
5730:
5726:
5722:
5717:
5710:
5705:
5703:
5698:
5696:
5691:
5690:
5687:
5674:
5671:
5667:
5666:
5662:
5660:
5656:
5655:
5651:
5650:
5647:
5643:
5636:
5632:
5631:
5627:
5625:
5621:
5620:
5616:
5614:
5610:
5609:
5605:
5601:
5599:
5595:
5594:
5590:
5586:
5585:
5582:
5577:
5573:
5565:
5561:
5556:
5551:
5547:
5543:
5539:
5535:
5531:
5526:
5523:
5520:
5517:
5514:
5513:
5500:
5496:
5492:
5488:
5484:
5480:
5476:
5472:
5464:
5448:
5444:
5438:
5430:
5426:
5421:
5416:
5411:
5406:
5402:
5398:
5394:
5387:
5379:
5375:
5370:
5365:
5361:
5357:
5353:
5349:
5345:
5338:
5330:
5326:
5321:
5316:
5312:
5308:
5304:
5297:
5289:
5285:
5281:
5277:
5273:
5269:
5265:
5261:
5253:
5245:
5241:
5236:
5231:
5227:
5223:
5219:
5215:
5211:
5204:
5196:
5192:
5188:
5184:
5180:
5176:
5172:
5168:
5161:
5153:
5149:
5145:
5140:
5135:
5131:
5127:
5126:Diabetes Care
5123:
5116:
5108:
5104:
5099:
5094:
5089:
5084:
5080:
5076:
5072:
5065:
5057:
5053:
5048:
5043:
5039:
5035:
5031:
5024:
5022:
5013:
5009:
5004:
4999:
4994:
4989:
4985:
4981:
4977:
4973:
4969:
4962:
4954:
4950:
4946:
4942:
4938:
4934:
4930:
4926:
4919:
4911:
4907:
4902:
4897:
4892:
4887:
4883:
4879:
4875:
4868:
4866:
4864:
4862:
4853:
4849:
4844:
4839:
4835:
4831:
4827:
4823:
4819:
4812:
4804:
4800:
4793:
4785:
4781:
4777:
4773:
4768:
4763:
4759:
4755:
4751:
4747:
4743:
4736:
4728:
4724:
4719:
4714:
4710:
4706:
4702:
4698:
4694:
4687:
4679:
4675:
4671:
4667:
4663:
4659:
4655:
4651:
4644:
4636:
4632:
4627:
4622:
4618:
4614:
4610:
4606:
4602:
4595:
4583:
4575:
4568:
4567:
4562:
4558:
4554:
4550:
4543:
4539:
4535:
4531:
4527:
4520:
4512:
4508:
4503:
4498:
4494:
4490:
4486:
4482:
4478:
4471:
4463:
4459:
4455:
4451:
4447:
4443:
4439:
4435:
4428:
4420:
4416:
4411:
4406:
4402:
4398:
4394:
4390:
4386:
4379:
4377:
4375:
4358:
4354:
4348:
4340:
4336:
4331:
4326:
4322:
4316:
4312:
4308:
4304:
4297:
4289:
4285:
4280:
4275:
4271:
4267:
4263:
4259:
4255:
4248:
4240:
4236:
4231:
4226:
4222:
4218:
4213:
4208:
4205:(22): 15231.
4204:
4200:
4196:
4189:
4181:
4177:
4172:
4167:
4163:
4159:
4155:
4148:
4140:
4136:
4131:
4126:
4122:
4118:
4114:
4107:
4099:
4095:
4090:
4085:
4081:
4077:
4073:
4066:
4064:
4055:
4051:
4046:
4041:
4037:
4033:
4029:
4022:
4020:
4018:
4009:
4005:
4000:
3995:
3991:
3987:
3983:
3979:
3975:
3968:
3960:
3956:
3951:
3946:
3942:
3938:
3934:
3927:
3919:
3915:
3911:
3908:(in German).
3907:
3900:
3892:
3888:
3883:
3878:
3874:
3870:
3866:
3859:
3857:
3848:
3844:
3840:
3836:
3831:
3826:
3822:
3818:
3814:
3807:
3799:
3795:
3791:
3787:
3783:
3779:
3771:
3763:
3759:
3755:
3751:
3747:
3743:
3739:
3735:
3727:
3719:
3715:
3711:
3707:
3703:
3699:
3695:
3691:
3684:
3676:
3672:
3668:
3664:
3660:
3656:
3649:
3640:
3636:
3632:
3625:
3617:
3613:
3609:
3605:
3600:
3595:
3591:
3587:
3583:
3576:
3568:
3566:9780323354790
3562:
3558:
3551:
3549:
3540:
3536:
3531:
3526:
3521:
3516:
3512:
3508:
3504:
3497:
3483:
3479:
3475:
3471:
3464:
3462:
3460:
3451:
3447:
3443:
3439:
3435:
3431:
3427:
3423:
3416:
3414:
3405:
3401:
3398:(2): 81–157.
3397:
3393:
3389:
3380:
3376:
3371:
3366:
3362:
3358:
3354:
3345:
3341:
3336:
3331:
3327:
3323:
3319:
3309:
3307:
3305:
3303:
3301:
3292:
3288:
3284:
3280:
3276:
3272:
3264:
3256:
3252:
3248:
3244:
3240:
3236:
3232:
3228:
3221:
3213:
3209:
3205:
3201:
3197:
3193:
3189:
3185:
3177:
3169:
3165:
3161:
3157:
3153:
3149:
3142:
3134:
3130:
3125:
3120:
3116:
3112:
3108:
3101:
3093:
3089:
3084:
3079:
3075:
3071:
3067:
3060:
3052:
3048:
3044:
3040:
3036:
3032:
3028:
3024:
3023:Diabetes Care
3017:
3009:
3005:
3000:
2995:
2991:
2987:
2983:
2979:
2975:
2968:
2966:
2964:
2962:
2960:
2951:
2947:
2943:
2939:
2932:
2924:
2920:
2915:
2910:
2906:
2902:
2898:
2891:
2883:
2879:
2874:
2869:
2865:
2861:
2857:
2850:
2842:
2838:
2834:
2830:
2825:
2820:
2816:
2812:
2808:
2801:
2799:
2797:
2781:
2777:
2771:
2756:
2752:
2745:
2743:
2741:
2739:
2730:
2726:
2721:
2716:
2712:
2708:
2704:
2700:
2696:
2689:
2687:
2679:
2678:
2673:
2668:
2666:
2664:
2655:
2651:
2646:
2641:
2636:
2631:
2627:
2623:
2619:
2612:
2604:
2598:
2590:
2586:
2582:
2580:9781260117431
2576:
2572:
2565:
2550:
2546:
2539:
2537:
2522:
2518:
2514:
2510:
2503:
2501:
2492:
2488:
2483:
2478:
2473:
2468:
2464:
2460:
2456:
2449:
2441:
2437:
2432:
2427:
2423:
2419:
2415:
2411:
2407:
2401:
2393:
2389:
2385:
2383:9781455737369
2379:
2375:
2368:
2360:
2356:
2352:
2348:
2341:
2333:
2329:
2325:
2321:
2317:
2313:
2306:
2298:
2294:
2290:
2286:
2282:
2278:
2274:
2270:
2262:
2254:
2250:
2245:
2240:
2236:
2232:
2228:
2224:
2220:
2213:
2211:
2209:
2200:
2196:
2192:
2188:
2181:
2173:
2169:
2164:
2159:
2155:
2151:
2147:
2143:
2139:
2132:
2130:
2121:
2117:
2113:
2109:
2105:
2101:
2093:
2091:
2089:
2087:
2085:
2083:
2081:
2079:
2077:
2075:
2066:
2064:9781259644047
2060:
2056:
2050:
2048:
2046:
2044:
2042:
2040:
2038:
2036:
2021:
2017:
2013:
2009:
2002:
1994:
1987:
1972:. McGraw Hill
1971:
1967:
1962:
1954:
1952:
1944:
1933:
1929:
1923:
1915:
1911:
1906:
1901:
1897:
1893:
1889:
1885:
1881:
1874:
1872:
1863:
1859:
1854:
1849:
1845:
1841:
1837:
1833:
1829:
1822:
1820:
1811:
1807:
1803:
1799:
1795:
1791:
1784:
1782:
1780:
1778:
1769:
1765:
1760:
1755:
1751:
1747:
1743:
1739:
1735:
1728:
1726:
1709:
1705:
1704:nhlbi.nih.gov
1701:
1695:
1693:
1684:
1680:
1675:
1670:
1666:
1662:
1658:
1651:
1649:
1647:
1630:
1626:
1620:
1618:
1609:
1605:
1601:
1597:
1593:
1589:
1585:
1581:
1573:
1571:
1569:
1567:
1565:
1548:
1544:
1543:nhlbi.nih.gov
1540:
1534:
1532:
1524:
1509:
1505:
1498:
1492:
1490:
1488:
1471:
1467:
1466:nhlbi.nih.gov
1463:
1457:
1455:
1453:
1451:
1449:
1447:
1430:
1426:
1425:nhlbi.nih.gov
1422:
1416:
1414:
1405:
1401:
1397:
1391:
1387:
1383:
1379:
1372:
1370:
1368:
1358:
1353:
1349:
1345:
1338:
1334:
1326:
1324:
1319:
1317:
1313:
1309:
1304:
1302:
1292:
1289:
1285:
1280:
1276:
1274:
1270:
1264:
1255:
1251:
1242:
1240:
1236:
1231:
1227:
1214:
1210:
1206:
1203:
1199:
1195:
1191:
1188:
1185:
1181:
1177:
1173:
1170:
1166:
1162:
1158:
1155:
1152:
1149:
1146:
1141:
1137:
1133:
1126:
1122:
1121:
1120:
1118:
1108:
1106:
1097:
1094:
1090:
1086:
1084:
1079:
1075:
1071:
1063:
1059:
1055:
1051:
1047:
1044:
1042:
1039:
1037:
1034:
1033:
1023:
1019:
1015:
1012:
1011:
1005:
997:
994:
990:
985:
979:
977:
967:
965:
960:
958:
948:
946:
938:
935:
932:
929:
928:
927:
921:
918:
915:
912:
911:
910:
908:
903:
898:
896:
888:
885:
882:
879:
876:
873:
870:
869:
868:
866:
862:
854:
850:
846:
843:
840:
837:
834:
833:
832:
830:
820:
811:
809:
805:
803:
799:
795:
791:
787:
783:
779:
775:
770:
766:
764:
760:
756:
748:
744:
740:
737:
734:
731:
728:
725:
721:
718:
715:
714:
713:
710:
702:
693:
691:
686:
681:
679:
674:
671:
667:
664:
659:
652:
640:
637:
633:
630:
626:
624:
620:
617:
613:
610:
607:
603:
600:
599:
598:
586:
583:
579:
575:
571:
567:
563:
559:
555:
551:
547:
543:
540:
536:
532:
531:
530:
521:
507:
505:
501:
497:
493:
489:
485:
481:
473:
470:
467:
464:
461:
458:
455:
454:
453:
450:
448:
444:
434:
425:
421:
419:
415:
411:
407:
403:
399:
395:
391:
387:
383:
379:
374:
372:
368:
364:
360:
356:
352:
348:
344:
340:
336:
332:
328:
324:
319:
317:
313:
309:
305:
301:
297:
293:
288:
286:
282:
278:
274:
269:
267:
263:
259:
254:
252:
248:
244:
240:
236:
232:
224:52,500 (2015)
223:
219:
215:
211:
208:
204:
200:
197:
195:
191:
187:
184:, supervised
183:
180:
176:
173:
169:
165:
162:
160:
156:
152:
148:
144:
140:
137:
135:
131:
128:
124:
121:
117:
114:
110:
108:
107:Complications
104:
100:
96:
92:
89:
87:
83:
80:
76:
73:
71:
67:
63:
58:
54:
49:
45:
41:
36:
30:
19:
6383:Hypertension
6295:Venous ulcer
6201:
6184:
6152:
6140:
6110:Inflammation
5991:
5950:
5839:Hyperplastic
5800:Fatty streak
5772:
5743:Inflammation
5663:
5652:
5628:
5617:
5602:
5587:
5537:
5533:
5474:
5470:
5463:
5451:. Retrieved
5437:
5400:
5396:
5386:
5351:
5347:
5337:
5310:
5306:
5296:
5263:
5259:
5252:
5217:
5213:
5203:
5170:
5166:
5160:
5129:
5125:
5115:
5078:
5074:
5064:
5037:
5033:
4975:
4971:
4961:
4928:
4924:
4918:
4881:
4877:
4825:
4821:
4811:
4802:
4792:
4749:
4745:
4735:
4700:
4696:
4686:
4653:
4649:
4643:
4608:
4604:
4594:
4580:{{
4572:{{
4565:
4563:,
4525:
4519:
4484:
4480:
4470:
4437:
4433:
4427:
4392:
4388:
4363:September 2,
4361:. Retrieved
4356:
4347:
4302:
4296:
4261:
4257:
4247:
4202:
4198:
4188:
4161:
4157:
4147:
4120:
4116:
4106:
4079:
4075:
4035:
4031:
3981:
3977:
3967:
3940:
3936:
3926:
3909:
3905:
3899:
3872:
3868:
3823:(1): 21–66.
3820:
3816:
3806:
3781:
3777:
3770:
3737:
3733:
3726:
3693:
3689:
3683:
3658:
3654:
3648:
3634:
3624:
3589:
3585:
3575:
3556:
3510:
3506:
3496:
3485:, retrieved
3473:
3425:
3421:
3395:
3391:
3360:
3356:
3325:
3321:
3274:
3270:
3263:
3233:(1): 13–18.
3230:
3226:
3220:
3187:
3183:
3176:
3154:(1): 86–96.
3151:
3148:Diabetologia
3147:
3141:
3114:
3110:
3100:
3073:
3069:
3059:
3026:
3022:
3016:
2981:
2977:
2941:
2937:
2931:
2904:
2900:
2890:
2863:
2859:
2849:
2814:
2810:
2783:. Retrieved
2779:
2770:
2760:December 14,
2758:. Retrieved
2755:Clinical Key
2754:
2702:
2698:
2675:
2625:
2621:
2611:
2570:
2564:
2554:November 10,
2552:. Retrieved
2548:
2524:, retrieved
2512:
2462:
2458:
2448:
2413:
2409:
2400:
2373:
2367:
2350:
2346:
2340:
2318:(2): 88–95.
2315:
2311:
2305:
2272:
2268:
2261:
2226:
2222:
2194:
2190:
2180:
2145:
2141:
2103:
2099:
2054:
2023:, retrieved
2011:
2001:
1992:
1986:
1974:. Retrieved
1969:
1965:
1942:
1935:. Retrieved
1931:
1922:
1887:
1883:
1835:
1831:
1793:
1789:
1741:
1737:
1714:February 26,
1712:. Retrieved
1703:
1664:
1660:
1633:. Retrieved
1583:
1579:
1553:February 26,
1551:. Retrieved
1542:
1522:
1517:February 26,
1515:. Retrieved
1503:
1476:February 25,
1474:. Retrieved
1465:
1435:February 26,
1433:. Retrieved
1424:
1377:
1347:
1337:
1323:gene therapy
1320:
1305:
1298:
1281:
1277:
1265:
1261:
1258:Epidemiology
1252:
1248:
1223:
1194:thrombectomy
1190:Thrombolysis
1178:has set in,
1114:
1098:
1087:
1078:antiplatelet
1067:
1003:
980:
973:
961:
954:
942:
925:
899:
892:
858:
825:
806:
771:
767:
752:
711:
707:
684:
682:
675:
672:
668:
660:
657:
629:renal artery
596:
578:Hypertension
570:triglyceride
554:Dyslipidemia
527:
515:Risk factors
477:
451:
439:
422:
375:
343:artery spasm
320:
304:tissue death
289:
270:
255:
234:
230:
229:
134:Risk factors
127:artery spasm
29:
6448:Hypotension
5992:head / neck
5844:Cholesterol
5734:capillaries
5654:MedlinePlus
5534:Circulation
5081:: 8295054.
5034:Circulation
4978:(7): 1041.
3586:Circulation
3386:Norgren L,
3111:Circulation
3070:Circulation
2901:Circulation
2628:(1): 4–10.
1209:lithotripsy
1151:Atherectomy
1132:Angioplasty
1083:rivaroxaban
1058:clopidogrel
855:of the limb
794:atherectomy
786:radio-dense
778:angiography
722:Noticeable
606:risk factor
562:cholesterol
539:endothelium
492:tissue loss
418:atherectomy
414:angioplasty
371:angiography
347:blood clots
300:bluish skin
296:skin ulcers
172:angiography
166:< 0.90,
111:Infection,
101:, cold skin
99:bluish skin
95:skin ulcers
43:Other names
6475:Categories
6364:Vasculitis
6354:Thrombosis
6315:Angiopathy
6259:Varicocele
6252:Hemorrhoid
6082:Halo nevus
5938:dissection
5729:arterioles
5630:DiseasesDB
4264:(2): 157.
3474:StatPearls
2817:(4): 362.
2785:October 4,
2589:1048597590
2513:StatPearls
2012:StatPearls
1329:References
1312:severe PAD
1220:Guidelines
1180:amputation
1089:Cilostazol
1030:Medication
1020:, and the
847:Stage IV:
690:Thrombosis
638:of 10%–20%
394:cilostazol
355:vasculitis
349:, trauma,
308:amputation
207:cilostazol
194:Medication
113:amputation
6118:Phlebitis
5859:Trans fat
5795:Foam cell
5751:Arteritis
5718:(vessels)
5673:emerg/862
5665:eMedicine
5453:August 5,
4953:214771540
4784:222151812
4582:retracted
4574:retracted
4221:1660-4601
3778:Radiology
3762:234684675
3487:April 10,
2841:108295670
2597:cite book
2526:April 10,
2465:(1): 29.
2392:810335904
2025:April 10,
1976:April 10,
1937:April 30,
1635:March 27,
1306:Only one
1245:Prognosis
1008:Lifestyle
1000:Treatment
951:Screening
945:angiogram
696:Diagnosis
549:diabetes.
378:screening
275:disease.
213:Frequency
188:, surgery
178:Treatment
70:Specialty
6332:Embolism
5934:Aneurysm
5871:Stenosis
5805:Atheroma
5756:Aortitis
5725:Arteries
5564:27840332
5499:13443907
5491:25770117
5447:Archived
5429:26739146
5378:27402237
5329:20435263
5288:54229954
5280:16325694
5244:35802393
5187:26631852
5152:Archived
5148:16567831
5107:32099582
5056:15262830
5012:35888129
4945:32240007
4910:17580733
4852:21963765
4776:32990327
4727:24959692
4678:18384741
4670:16286375
4561:29521415
4542:10796469
4511:33063850
4462:56484366
4454:30543542
4419:12637405
4339:30178370
4288:23504569
4239:36429951
4180:25721066
4139:29998344
4098:24126108
4054:24126108
4008:26908409
3918:14366554
3891:17140820
3839:16314696
3798:15858107
3754:33997924
3718:44960635
3710:19176443
3675:23993108
3639:Archived
3616:45644292
3608:23159553
3539:25993296
3482:28613496
3450:71164825
3442:17915154
3404:17489079
3388:Hiatt WR
3379:17223489
3344:17140820
3291:11368701
3255:13543458
3212:10716362
3204:16214597
3133:14517152
3092:14504252
3051:39307266
3008:23473760
2882:10206381
2833:30973629
2729:23093164
2654:28163401
2521:28613529
2491:27602234
2440:25530442
2359:22612053
2332:23485835
2289:24026319
2253:34192807
2199:Archived
2172:24711093
2163:11103656
2120:27851991
2020:32491414
1914:27733281
1862:27733282
1810:16449620
1768:29627967
1708:Archived
1683:24492064
1629:Archived
1608:38652734
1600:23915883
1547:Archived
1508:Archived
1506:. 2012.
1470:Archived
1429:Archived
1404:22918746
1295:Research
1202:embolism
1176:gangrene
1165:Gore-Tex
1052:such as
853:gangrene
829:ischemia
798:stenting
724:blueness
678:ischemia
663:etiology
504:gangrene
488:numbness
484:gangrene
406:warfarin
327:diabetes
277:Vascular
273:vascular
243:arteries
143:diabetes
86:Symptoms
6153:abdomen
5834:Hyaline
5670:med/391
5624:D016491
5555:5479414
5420:4704263
5369:5015366
5235:9266992
5195:3070349
5098:7024142
5003:9320565
4980:Bibcode
4901:1994028
4843:4714326
4767:8513671
4718:6544814
4635:2959214
4626:1493220
4502:8094235
4410:1125476
4330:6367927
4279:3597748
4230:9690814
3999:4802465
3959:9308598
3847:8026674
3530:4463701
3247:3965550
3168:7744233
2999:4492473
2950:8211690
2938:Surgery
2923:2242518
2720:3733106
2645:5248418
2482:5011891
2431:4340604
2297:9350462
2244:8245159
1905:5388903
1853:5055577
1759:6513337
1062:Statins
1054:aspirin
685:in situ
631:disease
573:stroke.
398:Aspirin
386:statins
285:veinous
281:veinous
237:) is a
199:Statins
5659:000170
5562:
5552:
5497:
5489:
5427:
5417:
5403:: 11.
5397:Trials
5376:
5366:
5327:
5286:
5278:
5260:Lancet
5242:
5232:
5193:
5185:
5146:
5105:
5095:
5054:
5010:
5000:
4951:
4943:
4908:
4898:
4850:
4840:
4782:
4774:
4764:
4725:
4715:
4676:
4668:
4633:
4623:
4559:
4555:,
4540:
4509:
4499:
4460:
4452:
4417:
4407:
4337:
4327:
4317:
4286:
4276:
4237:
4227:
4219:
4178:
4137:
4096:
4052:
4006:
3996:
3957:
3916:
3889:
3845:
3837:
3796:
3760:
3752:
3716:
3708:
3673:
3614:
3606:
3563:
3537:
3527:
3480:
3448:
3440:
3402:
3377:
3342:
3289:
3253:
3245:
3210:
3202:
3184:Lancet
3166:
3131:
3090:
3049:
3043:520114
3041:
3006:
2996:
2948:
2921:
2880:
2839:
2831:
2727:
2717:
2652:
2642:
2587:
2577:
2519:
2489:
2479:
2438:
2428:
2410:Lancet
2390:
2380:
2357:
2330:
2295:
2287:
2251:
2241:
2170:
2160:
2118:
2061:
2018:
1912:
1902:
1884:Lancet
1860:
1850:
1832:Lancet
1808:
1766:
1756:
1681:
1606:
1598:
1580:Lancet
1402:
1392:
1288:type 2
1284:type 1
1269:blacks
1184:sepsis
1074:stroke
1048:, and
849:ulcers
743:pallor
608:status
510:Causes
502:, and
447:oxygen
416:, and
392:, and
353:, and
316:stroke
221:Deaths
119:Causes
6268:Other
6101:Veins
5951:torso
5893:Other
5635:31142
5613:443.9
5598:I73.9
5495:S2CID
5284:S2CID
5191:S2CID
4949:S2CID
4780:S2CID
4674:S2CID
4578:with
4458:S2CID
3843:S2CID
3758:S2CID
3714:S2CID
3612:S2CID
3446:S2CID
3251:S2CID
3208:S2CID
3047:S2CID
2837:S2CID
2293:S2CID
1604:S2CID
1511:(PDF)
1500:(PDF)
1174:When
1147:open.
790:X-ray
560:(LDL
314:; or
251:brain
247:heart
6202:head
5732:and
5619:MeSH
5608:9-CM
5560:PMID
5487:PMID
5455:2015
5425:PMID
5374:PMID
5325:PMID
5276:PMID
5240:PMID
5218:2022
5183:PMID
5144:PMID
5103:PMID
5079:2019
5052:PMID
5008:PMID
4972:Life
4941:PMID
4906:PMID
4848:PMID
4772:PMID
4750:2020
4723:PMID
4701:2014
4666:PMID
4631:PMID
4557:PMID
4538:PMID
4507:PMID
4485:2020
4450:PMID
4415:PMID
4365:2023
4335:PMID
4315:ISBN
4284:PMID
4235:PMID
4217:ISSN
4176:PMID
4135:PMID
4117:JAMA
4094:PMID
4050:PMID
4004:PMID
3955:PMID
3914:PMID
3887:PMID
3835:PMID
3794:PMID
3750:PMID
3706:PMID
3690:JAMA
3671:PMID
3604:PMID
3561:ISBN
3535:PMID
3489:2023
3478:PMID
3438:PMID
3400:PMID
3375:PMID
3340:PMID
3287:PMID
3271:JAMA
3243:PMID
3200:PMID
3164:PMID
3129:PMID
3088:PMID
3039:PMID
3004:PMID
2946:PMID
2919:PMID
2878:PMID
2829:PMID
2787:2021
2762:2018
2725:PMID
2699:JAMA
2650:PMID
2603:link
2585:OCLC
2575:ISBN
2556:2021
2528:2023
2517:PMID
2487:PMID
2436:PMID
2388:OCLC
2378:ISBN
2355:PMID
2328:PMID
2285:PMID
2249:PMID
2227:2021
2168:PMID
2116:PMID
2059:ISBN
2027:2023
2016:PMID
1978:2023
1939:2019
1910:PMID
1858:PMID
1806:PMID
1790:JAMA
1764:PMID
1742:2018
1716:2015
1679:PMID
1637:2015
1596:PMID
1555:2015
1519:2015
1478:2015
1437:2015
1400:PMID
1390:ISBN
1286:and
1228:and
1192:and
1169:PTFE
1056:and
482:and
369:and
266:legs
5849:LDL
5604:ICD
5589:ICD
5550:PMC
5542:doi
5538:135
5479:doi
5415:PMC
5405:doi
5364:PMC
5356:doi
5315:doi
5268:doi
5264:366
5230:PMC
5222:doi
5175:doi
5134:doi
5093:PMC
5083:doi
5042:doi
5038:110
4998:PMC
4988:doi
4933:doi
4896:PMC
4886:doi
4838:PMC
4830:doi
4803:FDA
4762:PMC
4754:doi
4713:PMC
4705:doi
4658:doi
4621:PMC
4613:doi
4609:206
4549:doi
4530:doi
4497:PMC
4489:doi
4442:doi
4405:PMC
4397:doi
4393:326
4389:BMJ
4325:PMC
4307:doi
4274:PMC
4266:doi
4225:PMC
4207:doi
4166:doi
4125:doi
4121:320
4084:doi
4040:doi
3994:PMC
3986:doi
3945:doi
3877:doi
3825:doi
3786:doi
3782:235
3742:doi
3698:doi
3694:301
3663:doi
3594:doi
3590:126
3525:PMC
3515:doi
3430:doi
3365:doi
3330:doi
3279:doi
3275:285
3235:doi
3192:doi
3188:366
3156:doi
3119:doi
3115:108
3078:doi
3074:108
3031:doi
2994:PMC
2986:doi
2942:114
2909:doi
2868:doi
2819:doi
2715:PMC
2707:doi
2703:308
2674:at
2640:PMC
2630:doi
2477:PMC
2467:doi
2426:PMC
2418:doi
2414:385
2320:doi
2277:doi
2273:159
2239:PMC
2231:doi
2158:PMC
2150:doi
2108:doi
1900:PMC
1892:doi
1888:388
1848:PMC
1840:doi
1836:388
1798:doi
1794:295
1754:PMC
1746:doi
1669:doi
1588:doi
1584:382
1382:doi
1352:doi
1200:or
1167:or
1103:on
1070:AMI
851:or
249:or
235:PAD
60:An
6477::
5953::
5936:/
5727:,
5668::
5657::
5633::
5622::
5611::
5596::
5593:10
5558:.
5548:.
5536:.
5532:.
5493:.
5485:.
5475:20
5473:.
5423:.
5413:.
5401:17
5399:.
5395:.
5372:.
5362:.
5350:.
5346:.
5323:.
5311:51
5309:.
5305:.
5282:.
5274:.
5262:.
5238:.
5228:.
5216:.
5212:.
5189:.
5181:.
5171:39
5169:.
5150:.
5142:.
5130:29
5128:.
5124:.
5101:.
5091:.
5077:.
5073:.
5050:.
5036:.
5032:.
5020:^
5006:.
4996:.
4986:.
4976:12
4974:.
4970:.
4947:.
4939:.
4929:81
4927:.
4904:.
4894:.
4880:.
4876:.
4860:^
4846:.
4836:.
4826:58
4824:.
4820:.
4801:.
4778:.
4770:.
4760:.
4748:.
4744:.
4721:.
4711:.
4699:.
4695:.
4672:.
4664:.
4652:.
4629:.
4619:.
4607:.
4603:.
4536:.
4505:.
4495:.
4483:.
4479:.
4456:.
4448:.
4438:34
4436:.
4413:.
4403:.
4391:.
4387:.
4373:^
4355:.
4333:.
4323:.
4313:.
4282:.
4272:.
4260:.
4256:.
4233:.
4223:.
4215:.
4203:19
4201:.
4197:.
4174:.
4162:61
4160:.
4156:.
4133:.
4119:.
4115:.
4092:.
4080:59
4078:.
4074:.
4062:^
4048:.
4036:59
4034:.
4030:.
4016:^
4002:.
3992:.
3980:.
3976:.
3953:.
3941:26
3939:.
3935:.
3910:21
3885:.
3873:33
3871:.
3867:.
3855:^
3841:.
3833:.
3821:16
3819:.
3815:.
3792:.
3780:.
3756:.
3748:.
3738:37
3736:.
3712:.
3704:.
3692:.
3669:.
3659:27
3657:.
3637:.
3633:.
3610:.
3602:.
3588:.
3584:.
3547:^
3533:.
3523:.
3511:16
3509:.
3505:.
3472:,
3458:^
3444:.
3436:.
3426:60
3424:.
3412:^
3396:26
3394:.
3384:*
3373:.
3361:45
3359:.
3355:.
3349:*
3338:.
3326:33
3324:.
3320:.
3314:*
3299:^
3285:.
3273:.
3249:.
3241:.
3231:33
3229:.
3206:.
3198:.
3186:.
3162:.
3152:38
3150:.
3127:.
3113:.
3109:.
3086:.
3072:.
3068:.
3045:.
3037:.
3025:.
3002:.
2992:.
2982:61
2980:.
2976:.
2958:^
2940:.
2917:.
2905:82
2903:.
2899:.
2876:.
2864:20
2862:.
2858:.
2835:.
2827:.
2815:51
2813:.
2809:.
2795:^
2778:.
2753:.
2737:^
2723:.
2713:.
2701:.
2697:.
2685:^
2662:^
2648:.
2638:.
2626:25
2624:.
2620:.
2599:}}
2595:{{
2583:.
2547:.
2535:^
2511:,
2499:^
2485:.
2475:.
2461:.
2457:.
2434:.
2424:.
2412:.
2408:.
2386:.
2351:85
2349:.
2326:.
2316:42
2314:.
2291:.
2283:.
2271:.
2247:.
2237:.
2225:.
2221:.
2207:^
2195:90
2193:.
2189:.
2166:.
2156:.
2144:.
2140:.
2128:^
2114:.
2104:69
2102:.
2073:^
2034:^
2010:,
1970:20
1968:.
1964:.
1950:^
1941:.
1930:.
1908:.
1898:.
1886:.
1882:.
1870:^
1856:.
1846:.
1834:.
1830:.
1818:^
1804:.
1792:.
1776:^
1762:.
1752:.
1740:.
1736:.
1724:^
1702:.
1691:^
1677:.
1665:78
1663:.
1659:.
1645:^
1616:^
1602:.
1594:.
1582:.
1563:^
1541:.
1530:^
1521:.
1502:.
1486:^
1464:.
1445:^
1423:.
1412:^
1398:.
1388:.
1366:^
1350:.
1346:.
1275:.
1101:12
1060:.
947:.
897:.
831::
498:,
420:.
412:,
388:,
345:,
329:,
310:;
298:,
205:,
201:,
170:,
149:,
145:,
141:,
125:,
97:,
93:,
77:,
6130:/
5940:/
5708:e
5701:t
5694:v
5606:-
5591:-
5581:D
5566:.
5544::
5501:.
5481::
5457:.
5431:.
5407::
5380:.
5358::
5352:5
5331:.
5317::
5290:.
5270::
5246:.
5224::
5197:.
5177::
5136::
5109:.
5085::
5058:.
5044::
5014:.
4990::
4982::
4955:.
4935::
4912:.
4888::
4882:3
4854:.
4832::
4805:.
4786:.
4756::
4729:.
4707::
4680:.
4660::
4654:4
4637:.
4615::
4588:)
4586:.
4551::
4544:.
4532::
4513:.
4491::
4464:.
4444::
4421:.
4399::
4367:.
4341:.
4309::
4290:.
4268::
4262:6
4241:.
4209::
4182:.
4168::
4141:.
4127::
4100:.
4086::
4056:.
4042::
4010:.
3988::
3982:5
3961:.
3947::
3920:.
3893:.
3879::
3849:.
3827::
3800:.
3788::
3764:.
3744::
3720:.
3700::
3677:.
3665::
3618:.
3596::
3569:.
3541:.
3517::
3452:.
3432::
3406:.
3381:.
3367::
3346:.
3332::
3293:.
3281::
3257:.
3237::
3214:.
3194::
3170:.
3158::
3135:.
3121::
3094:.
3080::
3053:.
3033::
3027:2
3010:.
2988::
2952:.
2925:.
2911::
2884:.
2870::
2843:.
2821::
2789:.
2764:.
2731:.
2709::
2656:.
2632::
2605:)
2591:.
2558:.
2493:.
2469::
2463:3
2442:.
2420::
2394:.
2361:.
2334:.
2322::
2299:.
2279::
2255:.
2233::
2174:.
2152::
2146:4
2122:.
2110::
2067:.
1995:.
1916:.
1894::
1864:.
1842::
1812:.
1800::
1770:.
1748::
1718:.
1685:.
1671::
1639:.
1610:.
1590::
1557:.
1480:.
1439:.
1406:.
1384::
1360:.
1354::
1204:.
618:)
233:(
153:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.